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Abstract 
 
In recent years Wnt-Signaling has been implicated to play an important role in the 
control of differentiation of mesenchymal cells to chondrocytes. A key observation 
has been that stabilization of β-catenin in the early limb bud mesenchyme represses 
differentiation of mesenchymal cells into skeletal precursors. Probably this is 
mediated by transcriptional repression of the transcription factor Sox9, which is a 
master regulator in chondrocyte differentiation. 
The object of this thesis was to identify putative mediators of this Sox9 repression. 
Target genes of canonical Wnt signaling in limb bud development were identified and 
tested for their potential to repress Sox9. 
To do so I used gene expression data already available. I validated 48 candidate 
genes suggested by the data analysis using in situ hybridisation and semi-
quantitative RT-PCR, respectively. 10 genes could be confirmed as being positively 
regulated in the limbs of β-catenin gain of function mice. For three of them, the 
transcription factors Tcf4 (Itf2), Irx5 and Fosl2 (FRA2), I cloned parts of their 
promoters into luciferase reporter vectors and tested their response to β-catenin/Wnt-
signaling. Furthermore I cloned their cDNAs and tested their effect on part of the 
Sox9 promoter in luciferase reporter assays. For Tcf4 and Irx5 I could confirm their 
positive response to canonical Wnt-signaling, as well as their potential to repress 
Sox9 in vitro. 
To gain insight into the in vivo function of these genes, constructs for specific 
overexpression in the early limb bud mesenchyme have been generated. By the end 
of the thesis work one round of pronucleus injections has been carried out for the 
gene Tcf4, which yielded in one transgenic embryo with a strong limb phenotype. 
Unfortunately further analysis was not carried out due to the fact of the diploma work 
had ended. 
In conclusion this work suggests a number of new genes as targets of Wnt/β-catenin 
signaling in limb development. For two of them Irx5 and Tcf4 I established a possible 
direct regulation by the β-catenin/Wnt-pathway and that they have the potential to 
inhibit Sox9 at least in vitro. Further studies would now be necessary to examine 
whether they also excert a negative effect on Sox9 in vivo and to establish their 
potential functions during limb development. 
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Zusammenfassung 
 
Untersuchungen der letzten Jahre führten zum β-catenin/Wnt-Signalweg als 
möglichen Schlüssel zur Kontrolle der Differenzierung von mesenchymalen Zellen zu 
Knorpelzellen. Stabilisierung von β-catenin in der frühen Gliedmaßenanlage scheint 
die Expression des Transkriptionsfaktors Sox9 und damit die Differenzierung in 
Knorpelzellen zu inhibieren. Es ist jedoch unklar wie diese Kontrolle von Sox9 durch 
β-catenin/Wnt erfolgt. Diese Diplomarbeit ist Teil eines Projektes das zum Ziel hat 
den Mechanismus dieser Kontrolle aufzuklären. 
Dazu sollen β-catenin/Wnt-regulierte Gene der frühen Gliedmaßenentwicklung 
identifiziert und auf einen möglichen Einfluss auf die Sox9-Expression getestet 
werden. Am Beginn dieser Diplomarbeit standen bereits Daten einer Genexpres-
sionsstudie zur Verfügung. Nach Analyse dieser Daten wurden 48 mögliche 
Kanditatengene mittels In-situ-Hybridisierung bzw. RT-PCR validiert. Es konnten so 
10 Gene identifiziert werden, welche in der Gliedmaßenanlage von Embryonen, die 
konditionell stabilisiertes β-catenin expremieren, hochreguliert sind. Darunter 
befanden sich die Transkriptionsfaktoren Tcf4 (Itf2), Irx5 und Fra2 (Fosl2). Die 
Promotoren dieser Gene wurden in Luciferase Reporter Assays auf ihre β-
catenin/Wnt Abhängigkeit untersucht. Weiteres wurden diese Gene in Luciferase 
Assays mit einem Sox9-Promoter-Reporterkonstrukt getestet. Um Hinweise auf die 
Funktion der Gene in vivo zu erhalten wurden die kodierenenden Regionen der Gene 
in einen Vektor kloniert, welcher eine transiente Überexpression in transgenen 
Embryos erlauben sollte. Für das Gen Tcf4 wurde eine erste Runde von Injektionen 
durchgeführt. Diese lieferten jedoch nur einen transgenen Embryo, welcher jedoch 
einen Phenotyp in der Gliedmaßenanlage zeigte. Durch das zeitlich bedingte Ende 
der Arbeit waren leider keine weiteren Analysen möglich. Zusammenfassend wurden 
in dieser Arbeit eine Anzahl möglicher Zielgene des β-catenin/Wnt-Signalweges 
identifiziert. Für zwei davon Irx5 und Tcf4 ist eine direkte Abhängigkeit vom β-
catenin/Wnt Signalweg sehr wahrscheinlich. Weiters hatten beide Gene das Potential 
die Sox9-Expression zumindest in vitro zu inhibieren. Jedoch wären weitere 
Untersuchungen notwendig um eine mögliche Funktion dieser Gene in der 
Knorpelzellendifferenzierung bzw. Gliedmaßenentwicklung aufzudecken. 
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1. Introduction 
 
1.1 Relevance of the Research 
 
The endoskeleton is one of the key features of vertebrates in comparison to non-
vertebrates and a detailed understanding of its formation and maintenance is highly 
desirable as diseases of the musculoskeletal system as osteoporosis or osteoarthritis 
present a major burden to the health systems of industrialized countries. 
 
By studying the developmental processes forming the skeleton (skeletogenesis) its 
major cell types, osteoblasts and chondroblasts and the signaling pathways 
controlling their formation, differentiation and maturation researchers hope to find 
new approaches in cures for these diseases. In recent years major advances have 
been made in the characterization of molecular properties of these cells through the 
identification of key transcription factors and markers required for the formation and 
differentiation of these cells. For example Sox9 has been identified as a key factor in 
chondrocytes, while Runx2 and Osterix have been shown to be essential in 
osteoblasts, however the molecular mechanisms underlying the transcriptional 
regulation of these factors are still not well understood (Wagner and Karsenty 2001). 
 
1.2 Skeletogenesis 
 
Skeletogenesis can happen via to two distinct processes intramembranous 
ossification and endochondral ossification. The latter is the predominant process of 
bone formation in mammals as all bones of the axial and appendicular skeleton are 
formed by this process, while only the flat bones of the skull and lateral halves of the 
clavicles are entirely formed by a membranous ossification process. 
 
In intramembranous ossification condensed mesenchymal cells directly differentiate 
into osteoblasts, whereas in endochondral ossification mesenchymal cells first 
differentiate into chondrocytes that form a cartilage scaffold at the location of the 
future bone and prefiguring it in size and shape. Endochondral ossification is a step-
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wise process (Fig. 1) by which mesenchymal cells become committed to enter the 
chondrogenic lineage. First they condense into compact nodules a process 
dependent on the cell-cell adhesion molecules N-cadherin and N-CAM (Oberlender 
and Tuan 1994; Hall and Miyake 1995). In the next step chondrocytes proliferate 
rapidly and form the cartilage scaffold for the future bone, in parallel they secrete a 
cartilage specific extracellular matrix with Collagen type II (encoded by the Col2aI 
gene) and Aggrecan as the most prominent components. After the cartilage scaffold 
reaches a certain size cells in the centre stop to proliferate and undergo maturation to 
become first prehypertrophic and then hypertrophic chondrocytes (Horton, Machado 
et al. 1993). These cell types can be distinguished by their matrix as prehypertrophic 
chondrocytes still produce Collagen type II, whereas hypertrophic chondrocytes 
produce Collagen type X and Fibronectin instead (Linsenmayer, Chen et al. 1991; 
Poole, Matsuoka et al. 1991). The extracellular matrix secreted by the hypertrophic 
chondrocytes eventually becomes calcified and hypertrophic chondrocytes 
themselves undergo apoptosis.  
 
 
Fig.1: Steps of endochondral ossification (Hartmann 2006) 
 
During endochondral ossification the first osteoblasts are formed within the 
condensed layer of perichondrial cells, which surround the centre of the cartilage 
scaffold. This process is requires a signal from the prehypertrophic chondrocytes 
Indian hedgehog (IHH). Thereby the osteoblastogenesis is temporally coupled to 
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chondrogenesis (Kronenberg 2003). Hypertrophic chondrocytes also produce 
angiogenic factors attracting blood vessels, which eventually invade the calcified 
chondrocytic scaffold and bringing along osteoblasts, which start to form trabecular 
bone using the mineralized matrix scaffold of the hypertrophic chondrocytes as a 
template. In addition osteoclasts invade, whose function is to absorb bone and 
thereby help to maintain bone and calcium homeostasis during adult life.  
The maturation process of chondrocytes is controlled by a feedback loop consisting 
of parathyroid hormone related peptide (Pthrp) produced by proliferating 
chondrocytes at the articular ends of the forming skeletal elements and Ihh, which is 
produced by prehypertrophic chondrocytes (Fig. 2) (Kronenberg 2003). High levels of 
Pthrp signaling are thought to keep cells in the proliferative state thereby repressing 
maturation. Only cells that are far enough away can escape this repressive effect and 
mature into prehypertrophic Ihh producing cells. Ihh on the other hand is required to 
maintain high levels of Pthrp.  
 
 
Fig. 2: The PTHrP/Ihh negative feedback loop: PTHrP keeps cells proliferative and 
prevents differentiation (1). Ihh stimulates proliferation of columnar chondrocytes (2). 
Ihh stimulates osteoblastogenesis in the perichondrium (4) and proliferation (Kaiser 
Permanente (2009) in chondrocytes. Ihh stimulates PTHrP expression (3) 
(Kronenberg 2003) 
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1.3 The limb as a model for skeletogenesis 
 
A widely used model to study skeletogenesis is the limb of mouse and chicken, as 
the limbs of these organisms comprise major features of the human limb: They are 
formed by endochondral ossification, have synovial joints and a similar skeletal 
pattern. Furthermore, alterations in patterning can be easily identified. In addition the 
chicken limb is accessible to manipulation during embryogenesis.  
 
In embryonic development the vertebrate limb originates from the lateral plate 
mesoderm. Presumably Hox-Genes place the limb fields at the right places along the 
longitudinal axis of the embryo. Another important advantage of the limb is that the 
signaling centres determining the proximal-distal (P-D), anterior-posterior (A-P) and 
dorsal-ventral (D-V) pattering are relatively well understood (Fig. 3). 
In mice limb bud outgrowth starts at about E9,5 at the level of the forelimb and 
around E10 at the level of the hindlimb. A mesenchymal-epithelial feedback loop  
consisting of Fibroblast growth factor (Fgf) family members is responsible for the 
proximodistal growth and patterning by maintaining a population of multipotent 
progenitor cells in the most distal part of the limb bud (Yu and Ornitz 2008). The 
epithelial centre for this signaling system is localized in a thickening of the ectoderm, 
the so-called apical ectodermal ridge. It comprises one of the important pattering 
systems in the limb. Another well established patterning system is the zone of 
polarizing activity, which later on in development determines A-P patterning and 
thereby digit identity. The key to its function is a group of cells at the posterior margin 
producing the morphogen Sonic hedgehog, which forms a posterior to anterior 
gradient in the distal limb field (Riddle, Johnson et al. 1993). 
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Fig. 3: Signaling centers of the limb. AER – Apical Ectodermal Ridge, ZPA – Zone of 
polarizing activity, PZ progress zone.  
Source: http://www.cmrb.eu/centre-investigacio/en_desarrollo_miembros.html 
 
The third signaling centre determining the D-V identity (back vs. palms) is comprised 
out of non-AER dorsal ectoderm, which expresses as a key factor Wnt7a. Wnt7a is 
required to repress ventral ectodermal fate and to induce the expression o the 
transcription factor Lmx1b in the dorsal mesenchyme thus establishing dorsal (Parr, 
Shea et al. 1993). Whereas expression of the transcription factor engrailed 
establishes the ventral fate within the ectoderm (Cygan, Johnson et al. 1997). 
 
However, one important question has not yet been entirely solved: How is it achieved 
that the skeletal anlage is situated in the centre of the developing limb bud? Since 
this requires spatial and temporal regulation of cell fate determination this question 
goes hand in hand with the question: How is the expression of Sox9 the master-
regulator of chondrogenesis regulated? 
First insights into a possible mechanism came from the observation that the 
ectoderm can inhibit chondrogenesis (Solursh, Singley et al. 1981). Thus signals 
from the ectoderm might be involved in restricting chondrogenesis to the core of the 
limb bud. In particular Wnt-ligands, which are expressed in the limb ectoderm 
(Roelink and Nusse 1991; Parr, Shea et al. 1993; Barrow, Thomas et al. 2003), have 
been implicated as candidate signaling molecules as their overexpression can inhibit 
chondrogenesis in vitro (Rudnicki and Brown 1997; Hartmann and Tabin 2001). Thus 
Wnt-signaling is probably involved in this chondro-inhibitory effect. 
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1.4 WNT-signaling 
 
Wnt signaling pathways have been shown to participate in a number of biological 
processes eg embryonic development, tissue morphogenesis, body patterning, and 
tumorigenesis (Clevers 2006). The name Wnt is derived from the founding members 
encoded by the Drosophila wingless (Wg) gene and int-1, a viral inserted mutation 
causing mammary tumor in mice. Wnt genes encode secreted glycoproteins, which in 
addition are palmitoylated. A total of 19 Wnt genes have been identified in human 
and mouse. According to their activity in two assays, the Xenopus axis induction (Du, 
Purcell et al. 1995) and the transformation of mammary epithelial cell assays (Wong, 
Gavin et al. 1994) they have been subdivided in former times into two groups: The 
Wnt-1 class (eg Wnt-1, -3a, -7a, and 8) that activates the so called canonical Wnt 
pathway and the Wnt5-class (eg 4, 5a, and -11) that signals presumably via one of 
the noncanonical pathways. However, this subdivision is probably not really accurate 
as it has been shown that the signaling pathway utilized depends primarily on which 
receptors are present (He, Saint-Jeannet et al. 1997). 
 
The main Wnt-receptor a seven transmembrane receptor is encoded by the Frizzled 
(Fzd) gene family. It is proposed that activation of the canonical pathway requires in 
addition as coreceptors, either lipoprotein-related protein 5 or 6 (LRP-5, LRP-6), 
which are not required in non-canonical signaling (Clevers 2006). Extracellularly Wnt 
signaling is modulated by a number of secreted antagonists: Dickkopf (Dkk), which 
binds to LRP-5/6 and Kremen leading to an internalization of the complex thereby 
antagonizing canonical Wnt-signaling, secreted frizzled related protein (sFRP), which 
acts as a decoy receptor for the Wnt ligands, and Wnt inhibitory Factor (Wif), which 
also binds directly to Wnt ligands. Thus the latter two are thought to antagonize 
canonical as well as non-canonical Wnt-signaling. Recently a study has been 
published that argues that sFRPs not only inhibit Wnts but also can function to 
increase their range of diffusion within a tissue (Mii and Taira 2009). 
 
Activation of the canonical pathway leads to inhibition of the phosphorylation and 
degradation of the transcriptional cofactor β-catenin, which is mediated in the 
absence of a suitable Wnt-ligand by the destruction complex consisting of the 
glycogen synthase kinase GSK-3β, Axin and the scaffold protein Adenomatous 
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Polyposis Coli (APC). This inhibition is mediated by Dishevelled a factor that is 
phosphorylated by Casein Kinases, which themselves are activated by binding of 
Wnts to the LRP co-receptor (Clevers 2006). As a consequence the cytoplasmic level 
of unphosphorylated β-catenin increases and β-catenin is translocated into the 
nucleus where it acts as a coactivator for T-cell factors (Tcf7/Tcf7l1/Tcf7l2) and 
Lympymphoid enhancer binding factor 1 (Lef1) transcription factors (Clevers 2006). 
This activatory complex then turns on canonical Wnt-target genes as c-jun, c-myc, or 
E-cadherin (Willert, Epping et al.). 
 
Non-canonical Wnt signaling pathways are more divers and not yet completely 
understood, but have in common that they are β-catenin-independent. Two of the 
non-canonical pathways described are the Wnt/Ca2+-pathway, which is mediated by 
increase of intracellular Ca2+ concentrations and the planar cell polarity (PCP) 
pathway, which involves activation of Rho-GTPases (Clevers 2006). As non-
canonical pathways are not of interest for this thesis no further details are discussed. 
An overview of Wnt signaling pathways implicated in cartilage development is shown 
in Fig. 4. 
 
 
Fig. 4: Overview of the noncanonical and canonical Wnt-signaling pathways (Chun, 
Oh et al. 2008). 
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1.5 Sox9 – a master regulator of chondrogenesis 
 
Sox9 is a member of the family of Sox transcription factors that were initially identified 
as being related to Sry, the male Sex determination transcription factor localised on 
the Y-chromosom. They have a high mobility-group box (HMG) domain, which 
mediates DNA binding, DNA bending and interaction with other transcription factors. 
The Sry-related high-mobility-group box (Sox) family has 20 members in mouse and 
humans. Sox factors have been shown to act in organogenesis in different organs as 
testis, bone, or oligodentrocytes (Akiyama 2008). Some years ago mutations in Sox9 
were found to be the cause of Campomelic dysplasia a skeletal disease leading to a 
variety of symptoms including short stature and bowing of the limbs (Foster, 
Dominguez-Steglich et al. 1994; Wagner, Wirth et al. 1994). Analysis of the role of 
Sox9 in mice lead to the discovery that it controls amongst other genes the 
expression of Col2a1, which is highly expressed by chondrocytes (Ng, Wheatley et 
al. 1997; Zhao, Eberspaecher et al. 1997). Furthermore using conditional mouse 
models it was shown that Sox9 is essential for the condensation of the mesenchyme 
during limb skeletogenesis (Akiyama, Chaboissier et al. 2002), the commitment of 
osteochondroprogenitors, proliferation, differentiation, and maturation of chondro-
cytes and as a negative regulator of hypertrophic conversion (Akiyama 2008). The 
latter is thought to be in part mediated by its interaction with β-catenin on the protein 
level (Akiyama, Lyons et al. 2004), whereby Sox9 can interfere with canonical Wnt-
signaling (Topol, Chen et al. 2009).  
In essence Sox9 is thought to be the master regulatory gene for the chondrocytic 
lineage and as such the control of Sox9 expression is the key regulatory mechanism 
during chondrogenesis.  
 
 
1.6 Wnt Signaling in Skeletal development 
 
In the past our lab has investigated the role of Wnt/β-catenin signaling in limb 
development with a particular focus on skeletogenesis (Hill, Spater et al. 2005; Hill, 
Taketo et al. 2006; Spater, Hill et al. 2006). In these studies different β-catenin alleles 
were used: for the loss-of function (LOF) studies performed we used a mouse line 
carrying a β-catenin null allele (Huelsken, Vogel et al. 2000) in combination with a 
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conditional β-catenin loss of function allele (Huelsken, Vogel et al. 2001). For the 
gain-of function studies, in which constitutive activation of canonical signaling is 
achieved, a mouse line carrying the conditional β-catenin exon 3 floxed allele was 
used, which upon Cre-deletion leads to the formation of a truncated, stabilized form 
of β-catenin (Harada, Tamai et al. 1999). 
One of the key findings in our previous studies was that the Sox9 expression was 
expanded in β-catenin LOF limb buds and abolished in β-catenin GOF-limbs (Hill, 
Spater et al. 2005). This has led to our working-hypothesis that canonical Wnt-
signaling can repress Sox9 expression and thereby controls chondrogenesis and 
skeletal patterning (Fig. 5 A) 
Recent work by ten Berge and colleagues confirmed the chondro-inhibitory effect of 
Wnt-signaling and identified N-myc as a Wnt-target gene that promotes proliferation 
in subectodermal regions (ten Berge, Brugmann et al.). Furthermore they showed 
that concentration and duration of Wnt signaling is an important factor in cell fate 
determination and patterning for soft connective tissue in the limb. Their model 
integrating FGF and Wnt signaling is shown in Fig. 5 B. 
 
 
 
 
 
 
Fig. 5: Model of β-catenin/Wnt signaling in chondrocyte differentiation (A).  Model of 
FGF/Wnt signaling in limb patterning (ten Berge, Brugmann et al. 2008) (B) 
 
A
B 
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However, the question that remains is by which means represses Wnt-signaling Sox9 
and thereby chondrogenesis.  
As proliferation and differentiation often are mutual exclusive processes it could be 
that simply maintaining proliferation is sufficient to repress Sox9. However there are 
many factors known to prevent differentiation by inhibiting the genetic programmes 
directly. Therefore it could well be that canonical Wnt-signaling is either directly 
involved in the repression of Sox9 or indirectly through the upregulation of other 
transcription factors that then inhibit Sox9 expression. 
 
1.7 Aim of the thesis 
 
The main project of this thesis was part of an endeavour to uncover the potential 
mechanism by which canonical Wnt/ β-catenin signaling exhibits its chondroinhibitory 
effect and transcriptionally represses Sox9.  
Three different mechanisms would be feasible (see also Fig. 6) 
a) direct – (Tcf/Lef)/β-catenin act negatively on the Sox9 promoter  
b) Indirect – Wnt/β-catenin activates target genes (factor X) that repress Sox9  
c) combinatory – Factor X is activated by Wnt-signaling and acts in concert with 
components of the Wnt-pathway to repress Sox9  
 
 
Fig. 6: Potential mechanisms for Sox9 repression by canonical Wnt/β-catenin 
signaling. 
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Currently we have a team effort in our lab investigating the several different 
possibilities for Sox9 regulation by Wnt/β-catenin signaling (see Fig. 6). The work of 
this thesis was dedicated to identify transcription factors and other potential factors, 
which might act as the proposed factor X, and to investigate their role in Sox9 
regulation and limb development. 
 
1.8 Target genes of canonical Wnt-signaling in limb development 
 
As described above the possible factor X should be regulated by β-catenin/Wnt-
signaling. To identify such genes two members of the lab, Natalia Lyashenko and 
Daniela Kostanova-Poliakova, had carried out gene expression arrays using material 
from the conditional β-catenin mouse strains described above. 
These screens were carried out using mesenchymal cells, which have the potential to 
differentiate into chondrocyte precursors (E11.5) and Col2a1-expressing 
chondrocytes (E15.5). In detail E11.5 limb buds were isolated from mice homozygous 
for either the floxed lof allele or the floxed exon3 gof allele, single cell suspensions 
were generated from them, and cells were infected with adeno-gfp (control) or adeno-
cre and further cultured as high-density micromass cultures before isolation of the 
RNA at defined time points.  
For the isolation of chondrocytes, mice carrying the conditional β-catenin alleles were 
crossed with Col2-Gfp mice (Grant, Cho et al. 2000) in order to use fluorescence 
activated cell sorting (FACS) to isolate chondrocytes as the cells within the limbs at 
this stage of development are already very inhomogeneous. Isolated cells were then 
infected with the respective adeno-viruses and cultured under chondrogenic 
conditions. RNA was isolated at defined time points and either sent to Affymetrix for 
analysis on mouse gene expression array chips or analyzed on in house microarray 
chips. The process preceding the gene expression approach is outlined in Fig. 7. 
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Fig. 7: Summary of the gene expression study approach to identify β-catenin target 
genes in early limb development 
 
At the beginning of the thesis work the results from this gene expression profiling 
approach were already available in the lab. In more detail the aim of the thesis was to 
use the available expression data to identify potential Wnt-target genes in the limb, 
confirm their up-regulation in vivo (using in-situ hybridisation and RT-PCR) and select 
interesting target genes (candidates for factor X) for further analysis. This included 
cloning of their promoters to carry out Luciferase-reporter assays to confirm their 
regulation by a Lef/TCF-β-catenin complex. Furthermore it involved cloning of their 
full-length open-reading frames (ORFs) into expression vectors in order to test 
whether their expression had an effect on a Sox9-luciferase-reporter construct. 
Finally we wanted to look at the activity of potentially interesting factors with regard to 
chondrogenesis in vitro, using micromass culture systems and in vivo by generating 
transient transgenic mice overexpressing the factor of interest under the limb 
mesenchyme specific Prx1 promoter. An overview of the work is given in the flow 
chart shown in Fig. 8. 
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Fig. 8: Work flow overview of the thesis work 
 
 
In addition to the approach outlined above using the results from the gene expression 
analysis as a starting point, the promoters of two other genes: CyclinD1 a target of 
canonical Wnt-signaling (Shtutman, Zhurinsky et al. 1999; Tetsu and McCormick 
1999) and a member of the Tcf-family Tcf7l2 (Clevers 2006) were analyzed in 
luciferase reporter assays. 
This work was a follow-up based on the results gained by previous students in the 
lab, which had observed using in-situ hybridisations that both genes were down-
regulated in β-catenin GOF mice and up-regulated in β-catenin LOF mice. Their 
Promoter-studies were carried out test whether they are in vitro regulated by a 
Tcf/Lef-β-catenin complex according to the in vivo observations.  
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2. Results 
 
2.1. Candidate gene approach 
 
2.1.1 Tcf7l2  
 
Previously it has been shown that the nuclear Wnt-signaling components Lef1 and 
Tcf1 (Tcf7) are up-regulated in limbs upon conditional stabilization of β-catenin (Hill, 
Taketo et al. 2006). This indicates a positive auto-regulation of the pathway. 
Consequently, in-situ hybridisations have been carried out for Tcf7l2 (also known as 
Tcf4) another member of the Tcf/Lef family. For this factor, however the opposite was 
observed, a down-regulation in β-Catenin GOF and an up-regulation in β-catenin 
LOF limbs. 
In order to analyse whether Tcf7l2 is indeed negatively regulated by activation of the 
pathway I had isolated and cloned a 2,3 kb genomic region upstream of the Tcf7l2 
transcriptional start into the luciferase reporter vector pGL4 and carried out luciferase 
assays. Cotransfections were performed for the reporter vector and expression 
vectors for Lef1 and β-catenin, or Tcf1 and β-catenin into 293T cells in order to 
measure the effect on the luciferase activity. In addition a renilla plasmid was co-
transfected for normalisation purposes. 
In order to identify potential Tcf/Lef binding sites the up-stream region of Tcf7l2 had 
been subjected to a Transcription Element Search (Schug 2008) using the TESS 
system provided by the University of Pennsylvania (http://www.cbil.upenn.edu/cgi-
bin/tess/tess). This analysis resulted in the identification of 32 potential binding sites 
for Lef1/Tcf1 within the 2,4kb promoter region (Fig. 9 A). 
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Fig. 9: Predicted Tcf1/Lef1 binding sites on the Tcf7l2 promoter (A). Luciferase-assay 
with the reporter-construct shown in (A) and increasing amounts of Tcf1/β-catenin or 
Lef1/β-catenin (B). 
 
The luciferase results shown in Fig. 9 B clearly do not support the observations made 
in vivo. Opposite to the down-regulation that had been observed upon stabilization of 
β-catenin, in vitro an upregulation of up to 3-fold in the case of Tcf1/β-catenin co-
transfection and up to 12-fold upon Lef1/β-catenin expression. A similar difference in 
the efficiency of the two transcription factor complexes was observed throughout 
most of the experiments using different reporter constructs (also see below); where 
with few exceptions Lef1 always gave a stronger effect than Tcf1 in combination with 
β-catenin.  
From the above result it can be concluded, that the in vivo down-regulation may be 
due to secondary effects and is not directly mediated by Wnt/β-catenin signaling. 
 
2.1.2 CyclinD1 
 
The second candidate gene that I looked at was cyclinD1. Its regulation by Wnt-
signaling is particularly interesting as it is part of the cell-cycle regulation system and 
A 
B 
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as described in the introduction Wnt-signaling can promote proliferation in sub-
ectodermal limb mesenchyme. 
In other tissues/cells such as colon carcinoma cells CyclinD1 has been shown to be 
positively regulated by β-catenin (Shtutman, Zhurinsky et al. 1999; Tetsu and 
McCormick 1999). Previous members of the lab had carried out section in-situ 
hybridisations on β-catenin GOF and LOF limbs to check for a similar regulation in 
limb-development but they found instead of the expected up-regulation a down-
regulation of CyclinD1 in the β-catenin GOF limbs.  
Again in order to get an idea if this down-regulation of cyclin D1 observed in the limb 
bud mesenchyme may be mediated directly by canonical Wnt-signaling a part of the 
promoter was cloned into a luciferase reporter vector and luciferase assays were 
carried out. In addition, like in the case for all other potential target genes the 
promoter region was subjected to an in silico analysis for putative Tcf/Lef binding 
sites using TESS. This revealed the presence of 20 potential binding sites within the 
genomic 2,4 kb up-stream region of the cyclin D1 gene (Fig. 10 A).  
 
 
 
Fig. 10: Predicted Tcf1/Lef1 binding sites on the cyclinD1 promoter (A). Luciferase-
assay with the reporter-construct shown in (A) and increasing amounts of Tcf1/β-
catenin or Lef1/β-catenin (B). 
 
In the luciferase-assays (Fig. 10 B) a slight down-regulation of luciferase activity was 
observed upon co-transfection of Tcf1 and β-catenin or Lef1 and β-catenin. A dose 
B 
A 
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dependent effect was observed for Tcf1/β-catenin. For Lef1/β-catenin expression was 
decreased to about 0,6-fold with all concentrations. This suggests that cyclinD1 might 
indeed be negatively regulated by Wnt/β-catenin signaling; however, the repressive 
effect was not very strong and further investigations would be necessary to further 
confirm that cyclinD1 is repressed by the canonical Wnt-signaling in the limb 
mesenchyme. Due to emphasis on the main project described below no further 
experiments were carried out.  
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2.2. Identification and characterization of β-catenin deregulated 
genes. 
 
2.2.1 Primary Screen 
 
The data for the primary screen had been generated in the lab prior to my arrival as 
described in the introduction (Fig. 7). To identify potential candidate genes two 
different setups for the data analysis were used, which are summarized in Fig.11.  
In the first setup we selected for genes that were up-regulated in chondrocyte 
precursors expressing stabilized β-catenin (GOF) in comparison with the adeno-GFP 
infected controls and were down-regulated in cells in which β-catenin activity had 
been lost (LOF) in comparison with the control.  
 
 
Fig. 11: Overview of the gene expression array data analysis 
 
In the second setup, genes were selected that were up-regulated in chondrocyte 
precursors expressing stabilized β-catenin (GOF) as well as in chondrocytes, which 
expressed stabilized β-catenin (GOF). Both setups thereby should identify genes that 
are positively regulated by canonical Wnt-signaling and could play a role in 
transcriptional regulation or cell signaling. It is important to mention that the up-
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regulation in both cell types, precursors and chondrocytes, led to a repression of 
Sox9 expression. 
 
Next we sorted the set of genes selecting for functions in signaling and transcriptional 
regulation. Gene Ontology (GO) functional annotations were used to filter for genes 
associated with the following functions: effector of transcription, kinase or 
phosphatase function, GTP exchange factor (GEF) or GTPase activating protein 
(GAP). Details of the analysis are described in material & methods.  
 
The results from this analysis are shown in Table 1 and Table 2. The first setup 
yielded 16 genes shown in table 1.  
 
Table 1: Chondrocyte Precursors GOF vs. LOF 
 
Affymetrix ID Gene Description 
GOF (log 
fold-change) 
LOF (log fold-
change) 
1440370_at Abca13 ATP-binding cassette, sub-family A (ABC1), member 13 1.31 -0.70 
1458929_at Abca9 ATP-binding cassette, sub-family A (ABC1), member 9 0.67 -0.52 
1443870_at Abcc4 ATP-binding cassette, sub-family C (CFTR/MRP), member 4 0.70 -0.73 
1447301_at Akap5 A kinase (PRKA) anchor protein 5 1.37 -1.92 
1439892_at Brsk1 BR serine/threonine kinase 1 0.94 -0.37 
1440572_at Dusp19 dual specificity phosphatase 19 1.00 -1.25 
1422318_at Foxd4 forkhead box D4 0.98 -1.11 
1427494_at Hoxb7 homeo box B7 1.10 -1.07 
1454734_at Lef1 lymphoid enhancer binding factor 1 0.57 -0.53 
1422262_a_at Lhx6 LIM homeobox protein 6 0.56 -1.27 
1429833_at Ly6g6e lymphocyte antigen 6 complex, locus G6E 0.44 -1.56 
1439585_at Mdn1 midasin homolog (yeast) 2.41 -1.79 
1445134_at Mkl2 MKL/myocardin-like 2 0.42 -1.67 
1421704_a_at Pik3c2g phosphatidylinositol 3-kinase, C2 domain containing, gamma 
polypeptide 
1.87 -0.75 
1420637_at Prps2 phosphoribosyl pyrophosphate synthetase 2 0.57 -0.45 
1443786_at Utf1 undifferentiated embryonic cell transcription factor 1 0.5 -3.18 
 
 
The second analysis shown in table 2 yielded 42 genes. Some of the factors 
identified like Lef1, Tcf7, Twist1, En1, or Msx2 were already known targets of 
canonical Wnt signaling (Hooper 1994; Roose, Huls et al. 1999; Filali, Cheng et al. 
2002; Willert, Epping et al. 2002; Howe, Watanabe et al. 2003). Furthermore these 
genes had been characterized in the context of limb development in our lab and 
other labs as been regulated by Wnt/β-catenin signaling, which was reassuring that 
the experimental set-up, data-quality and analysis might be sufficient to identify 
genes in limb development that are regulated by canonical Wnt-signaling.  
25 
 
Table 2: Chondrocyte Precursor GOF vs. Chondrocytes GOF 
 
Affymetrix ID Gene Description 
GOF 
chondrocyte 
precursors 
(log fold-
change) 
GOF  
chondrocytes 
 
(log fold-change) 
     
1427490_at Abcb7 ATP-binding cassette, sub-family B (MDR/TAP), member 7 0.52 0.72 
1458455_at Abra actin-binding Rho activating protein 2.44 1.58 
1451867_x_at Arhgap6 Rho GTPase activating protein 6 0.61 1.04 
1436512_at Arl4c ADP-ribosylation factor-like 4C 0.60 0.96 
1426167_a_at Camk4 calcium/calmodulin-dependent protein kinase IV 1.21 2.12 
1449152_at Cdkn2b cyclin-dependent kinase inhibitor 2B (p15, inhibits CDK4) 1.15 0.79 
1436569_at Depdc2 DEP domain containing 2 0.49 0.75 
1418618_at En1 engrailed 1 0.95 1.15 
1455426_at Epha3 Eph receptor A3 0.61 0.75 
1427783_at Erbb4 v-erb-a erythroblastic leukemia viral oncogene homolog 4 (avian) 1.33 1.12 
1423232_at Etv4 ets variant gene 4 1.01 1.59 
1458961_at Eya3 eyes absent 3 homolog (Drosophila) 0.45 0.58 
1421442_at Flt4 FMS-like tyrosine kinase 4 0.58 1.14 
1437247_at Fosl2 fos-like antigen 2 0.84 0.54 
1444226_at Foxo3a forkhead box O3a 0.59 0.57 
1435283_s_at Gm967 gene model 967 0.51 0.45 
1454959_s_at Gnai1 guanine nucleotide binding protein (G protein), alpha inhibiting 1 0.44 0.58 
1422704_at Gyk glycerol kinase 0.65 0.50 
1421072_at Irx5 Iroquois related homeobox 5 (Drosophila) 0.87 0.41 
1454734_at Lef1 lymphoid enhancer binding factor 1 0.57 1.31 
1426516_a_at Lpin1 lipin 1 0.50 0.47 
1430564_at Mobkl1a MOB1, Mps One Binder kinase activator-like 1A (yeast) 0.73 0.59 
1449559_at Msx2 homeobox, msh-like 2 0.53 0.51 
1421867_at Nr3c1 nuclear receptor subfamily 3, group C, member 1 0.51 0.41 
1450821_at Pcaf p300/CBP-associated factor 0.47 1.16 
1451737_at Pik3r1 phosphatidylinositol 3-kinase, regulatory subunit, polypeptide 1 
(p85 alpha) 
0.77 2.72 
1443144_at Prkcb1 protein kinase C, beta 1 0.57 2.66 
1416588_at Ptprn protein tyrosine phosphatase, receptor type, N 0.76 1.87 
1427448_at Rabep1 rabaptin, RAB GTPase binding effector protein 1 0.44 0.72 
1451236_at Rerg RAS-like, estrogen-regulated, growth-inhibitor 0.83 2.64 
1436470_at Rims2 regulating synaptic membrane exocytosis 2 0.96 1.15 
1440878_at Runx1 runt related transcription factor 1 0.58 0.67 
1436499_at Sgms1 sphingomyelin synthase 1 0.41 0.52 
1432139_at Srpk3 serine/arginine-rich protein specific kinase 3 2.87 1.45 
1450997_at Stk17b serine/threonine kinase 17b (apoptosis-inducing) 0.72 0.42 
1421078_at Tcf23 transcription factor 23 2.84 1.23 
1433471_at Tcf7 transcription factor 7, T-cell specific 0.54 2.06 
1444730_at Tlk1 tousled-like kinase 1 1.36 0.82 
1418733_at Twist1 twist gene homolog 1 (Drosophila) 0.50 1.47 
1460104_at Vps4b vacuolar protein sorting 4b (yeast) 0.60 0.63 
1425425_a_at Wif1 Wnt inhibitory factor 1 0.51 3.14 
1434149_at Tcf4* Transcription factor 4*  1,78 
* This factor did not turn up in the data analysis but was confirmed before as upregulated in chondrocytes by D. Kostanova.  
 
 
As an additional validation of the data the results were clustered by use of the 
Database for Annotation, Visualization and Integrated Discovery = DAVID (Dennis, 
Sherman et al. 2003; Huang da, Sherman et al. 2009). This tool is available online 
(http://david.abcc.ncifcrf.gov/), it can be used to classify large gene list into functional 
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related gene groups and rank the importance of the discovered gene groups. To 
carry out this analysis the genes from both set-ups were merged.  
 
The results are shown in Fig. 12. As expected two major clusters appeared in the 
gene enrichment analysis. One cluster of 22 genes for transcription factors (Group1), 
many of them known to be involved in developmental processes or cell differentiation 
and a second cluster of 11 genes with putative functions in intracellular signaling 
(Group2). 15 genes were not accounted for in this analysis.  
 
 
Fig. 12: Gene functional enrichment analysis by DAVID 
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2.2.2 Secondary Screen 
 
To validate the 58 genes suggested by the analysis of gene expression data, whole 
mount in-situ hybridisations were performed for the majority of the genes using β-
cat∆ex3Prx1/+ (GOF) mice and their wild-type (WT)-littermates. For the five genes 
mentioned above that had previously been investigated in the context of Wnt-
signaling and limb development no in-situ hybridisations (ISH) were performed. For 
48 of the remaining 53 genes I generated in-situ probes. No probes were created for 
the genes: Tlk1, Vps4b, Arl4c, Abcc4, and Abca9 as suitable Riken clones were not 
available and Pcr-amplification did not succeed. The results from the whole mount in-
situ hybridisations (WM-ISH) are summarized the Table 3.  
 
Differential expression 
observed in wt versus 
gof 
Specific pattern but no 
differential expression 
observed 
Probe 
unspecific/expression 
pattern not detectable 
Fosl2 (Fra2), Irx5, Prkcb1, 
Runx1, Tcf4, Wif1 
 
 
 
 
 
 
Abcb7, Akap5, Brsk1*, 
Camk4, Cdkn2b, Depdc2, 
Epha3, Erbb4, Etv4, Eya3, 
Foxo3a*, Glyk, Gm967, 
Gnai1*, Hoxb7, Lhx6, 
Lipn1, Ly6g6e, Mdn1, 
Mkl2, Nr3c1, 
Pik3r1*Prps2, Rapeb1, 
Rims, Srpk3, Stk17b 
 
*for this genes differential expression 
was observed in Section ISH and/or RT-
PCR 
Abca13, Abra, Arhgap, 
Flt4, Fox4d, Pcaf, Pi3c2g, 
Rerg, Sgms1, Tcf23, Utf1 
Table3: Summary of the whole-mount In-situ hybridisation results 
 
Whole mount stainings in which a differential expression was visible are shown in 
Fig. 13. Examples for some of the other genes are shown in Figure 14. For most 
genes the sample size was n=1, for genes where a differential expression was 
observed or suspected after the initial first round staining a second sample was 
analyzed (n=2). 
In addition to the whole mount in-situ hybridizations I tried to confirm the differential 
gene expression using semi-quantitative RT-PCR on RNA isolated from the limb 
buds of E11,5 β-cat∆ex3Prx1/+ (GOF) mice and their WT-littermates. For a selected 
number of genes I finally performed section in-situ hybridisations.  
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The RT-PCRs were carried out to get an independent confirmation for the results 
from the WM-ISH and to detect differences in expression levels, which might have 
been not easily visually detectable on the whole-mount staining (Fig. 15). Section in-
situ hybridisations were performed to analyze the respective expression patterns 
inside the limb bud. Results from those are shown in Fig. 16.  
 
 
Fig. 13: Whole mount In-situ hybridisations. Genes with stronger expression in the β-
catenin GOF embryos 
 
 
Fig. 14: Examples of genes with limb specific expression, but no clearly detectable 
difference in the expression between WT and β-catenin GOF embryos 
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Fig. 15: Semi-Quantitative PCR 
Group 1 - genes that are 
upregulated in this assay as well as 
the WM-ISH.  
Group 2 - genes that have not been 
detected as upregulated in the WM-
ISH but show differential expression 
in the SQ-RT-PCR.  
Group 3 - examples of genes that 
were not differentially expressed in 
both assays. Gapdh: loading 
control, -RT not shown. 
 
 
Fig. 16: Section ISH for E11,5 embryos (A). Alternative WT-section for Irx5; arrows 
indicate subectodermal expression (B).  
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Based on the results from the secondary screens the following genes were 
considered to be positively regulated by Wnt/β-catenin signaling: Brsk1, Foxo3a, 
Fra2, Gnai1, Irx5, Pik3r1, Prkcb1, Runx1, Tcf4, and Wif1. For Brsk1 and Foxo3a this 
is based solely on the results from the semi-quantitative RT-PCR. For all other genes 
differential expression had been detected in WM-ISH, RT-PCR and Section-ISH.  
 
For our initial question concerning factors, which might be involved in the 
transcriptional regulation of Sox9, the genes Tcf4, Irx5 that encoded transcription 
factors and showed an interesting wild type expression patterns were of particular 
interest to us. For example, Tcf4 showed an expression pattern somewhat 
complementary to that of Sox9 and congruent to the localisation of Tcf1, Lef1 
transcripts and endogenous high levels of β-catenin protein (Hill, Spater et al. 2005; 
Hill, Taketo et al. 2006).  
For Irx5 we could also detect such a subectodermal expression pattern in the central 
region of the limb (Fig. 16 B) in addition to the strong proximal expression domain 
that has been documented previously (Houweling, Dildrop et al. 2001) (Fig. 16). 
Interestingly Irx5 upregulation in the β-catenin GOF limbs seems to be excluded from 
the most distal part of the limb (Fig. 13/Fig. 16). 
Eya3 was also interesting to us as it showed an expression pattern similar to that of 
Tcf4 in the wild-type; however β-catenin stabilization did not cause a detectable 
upregulation in the secondary screen assays conducted. 
Brsk1, Gnai1, Prkcb1 and Runx1 were confirmed relatively late during the screening 
process therefore it was not possible for time reasons to carry out any additional 
investigations for these genes. Wif1 was also not further investigated as it is known to 
be a regulator of Wnt-signaling and has already been investigated for its potential 
role in skeletogenesis (Hsieh, Kodjabachian et al. 1999; Surmann-Schmitt, Widmann 
et al. 2009).  
 
2.2.3 Confirmation of Wnt/β-catenin target genes by promoter studies 
 
Promoter studies in the response to β-catenin/Wnt signaling were carried out for 
Pik3r1 by the summer student Franz Gruber under my supervision, however as his 
results could not be reproduced by myself no further results are shown for this gene.  
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Furthermore promoter studies were carried out on the upstream regulatory regions of 
the transcription factors Tcf4, Fra2 (Fosl2) and Irx5. The expression of Tcf4 and Irx5 
had been up-regulated in GOF mutants as confirmed in my secondary screens and 
both genes showed interesting expression patterns in the wild-type. Fra2 was 
included because it was up-regulated and has already been shown to play a role in 
chondrocytes maturation (Karreth, Hoebertz et al. 2004).  
 
2.2.3.1 Fra2 shows no response to canonical Wnt signaling and only a 
neglectabe effect on Sox9 expression in vitro 
 
Fra2 is a member of the AP1 (activating protein 1) family and is encoded by the Fosl2 
gene. The AP1 transcription factor consists of dimers of members formed by either 
heterodimers of Fos (Fos, Fra1, Fra2 and FosB) and Jun (Jun, JunB and JunD) 
members, which encode basic leucine zipper domain proteins, or homodimers of Jun 
family members. AP1 has been shown to be involved into developmental processes 
as cell differentiation or apoptosis as well as in oncogenic transformation (Jochum, 
Passegue et al. 2001). Fra2 has previously been shown to have an effect on 
chondrocyte maturation (Karreth, Hoebertz et al. 2004). However this study did not 
investigate a potential influence of Fra2 on early differentiation events as for example 
an influence on Sox9 expression. A potential regulation of Fra2 expression by the 
canonical Wnt-signaling pathway was also not known. In contrast to other AP1 
components, such as Fra1 and c-Jun, which have been described as direct targets of 
Wnt-signaling in human colonic adenocarcinomas (Mann, Gelos et al. 1999).  
To address whether Fra2 is regulated by the canonical Wnt-pathway I cloned a 1,9 
kb genomic up-stream region of its promoter into a luciferase reporter vector. 
Bioinformatic analysis of the Fra2 promoter revealed 24 potential binding sites for 
Lef1/TCF1 within the 1,9 kb up-stream region. However, when the promoter was 
tested for its responsiveness to Lef1 and TCF1 in combination with their cofactor β-
catenin in 293T cells, no upregulation was detectible (Fig. 17). This result suggests 
that Fra2 is not a direct target of the canonical Wnt-pathway.  
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Fig. 17: Predicted Tcf1/Lef1 binding sites on the Fra2 promoter (A). Luciferase-assay 
with the reporter-construct shown in (A) and increasing amounts of Tcf1/β-catenin or 
Lef1/β-catenin (B). 
 
To investigate if Fra2 could have an effect on Sox9 I had cloned the Fra2 ORF into 
an expression vector and co-transfected the Fra2 expression construct with a 2.9 kb 
Sox9 luciferase reporter, which had previously been generated in our lab by others. 
My bioinformatical analysis of the Sox9 reporter indicated the presence of 25 putative 
AP1 binding sites (Fig. 18).  
 
 
 
Fig. 18: Predicted AP1 binding sites on the Sox9 promoter (A). Luciferase-assay 
with the reporter-construct shown in (A) and increasing amounts of Fra2 expression 
vector (B). 
 
A 
B 
A 
B 
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The luciferase assay revealed only a slight down-regulation to a maximum of 0,8-fold 
with the highest concentration of expression vector used (Fig. 18). This result 
suggests that Fra2 may not have an effect on Sox9 expression. 
 
2.2.3.2 Irx5 can be induced by canonical Wnt signaling and represses Sox9 in 
vitro 
 
Iroquois genes have first been identified in the IRX-C complex of Drosophila 
melanogaster, which contains the three highly similar homebox genes araucan 
(orthologue to IRX1,3), caupolican (orthologue to IRX2,5), and mirror (orthologue to 
IRX4,6). These genes have a conserved homeodomain of the three-amino acid 
length extension (TALE) superclass and a familiy specific conserved 13 amino acid-
residue motif, the so-called Irobox (Burglin 1997).  
Vertebrates have six Irx-gene homologues, which are arranged in two genomic 
clusters - one consisting of Irx1, Irx2, and Irx4 and the second of Irx3, Irx5 and Irx6 
and probably arose by duplication of the IRX-C complex (Peters, Dildrop et al. 2000). 
It is has been shown in various species that Irx genes play a role in specifying tissue 
patterns during development (Cavodeassi, Modolell et al. 2001).  
In the vertebrate limbs Irx genes are expressed in well defined patterns with Irx1 and 
Irx2 being expressed in the digit condensations at E13.5 and the future joint regions 
at E14.5, while Irx3 and Irx5 are mainly found in the proximal region of the limb at 
E11.5 and in the interdigital mesenchyme at E13.5 (Houweling, Dildrop et al. 2001). 
So far there have been no published studies reporting a function of IRX genes in limb 
development.  
In order to address whether Irx5 is regulated by a β-catenin/Tcf transcriptional 
complex, we searched for the presence of potential Tcf/Lef binding sites in the up-
stream regulatory region. This revealed the presence of 24 potential sites within a 1,9 
kb region (Fig. 19A). Next I isolated and cloned this 1,9kb region of the putative Irx5-
promoter region into a pGL4 vector and tested for its responsiveness to the canonical 
Wnt transcriptional mediators Tcf1/β-catenin and Lef1/β-catenin, respectively. For 
both combinations a dose dependent up-regulation could be observed. Tcf1/β-
catenin could induce a 2-fold upregulation, when 1µg of both expression vectors was 
used. A similar level of activation could already be observed at 0,25 µg and 0,5 µg of 
Lef1/β-catenin expression vectors. At the concentration of 1µg of Lef1/β-catenin a 
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very significant increase in activity was observed in measurements conducted (Fig. 
19). 
 
 
 
Fig. 19: Predicted Tcf1/Lef1 binding sites on the Irx5 promoter (A). Luciferase-assay 
with the reporter-construct shown in (A) and increasing amounts of Tcf1/β-catenin or 
Lef1/β-catenin (B). 
 
To test if Irx5 could be the factor X influencing Sox9 expression I cloned the coding 
region into an expression vector and co-transfected it with the 2,9kb Sox9-luciferase 
reporter construct into 293T cells. Up to now no canonical binding site for the IRX 
transcription factors has been published, however using Uniprobe a data collection 
based on protein/DNA binding arrays suggests the presence of three potential sites 
within the 2,9kb Sox9 promoter region (Newburger and Bulyk 2009) (see Fig. 20A).  
A 
B 
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Fig. 20: Predicted Irx5 binding sites on the Sox9 promoter (A). Luciferase-assay with 
the reporter-construct shown in (A) and increasing amounts of Irx5 expression vector 
(B). 
 
Co-transfection of the Irx5 expression plasmid resulted in a strong dose dependent 
repression of the luciferase signal with a reduction down to 0,3-fold of the signal with 
the highest concentration of Irx5 expression vector (Fig. 20B). 
Given the strong repressive in vitro activity of Irx5 on the Sox9 promoter I constructed 
a Prx1-Irx5pA transgenic construct to study the in vivo function of Irx5 upon 
overexpression in the limb-mesenchyme. Unfortunately the pro-nucleus injections 
could not been carried out within the time frame of my thesis work. 
 
 
2.2.3.3 Tcf4 is up-regulated by canonical Wnt signaling and represses Sox9 in 
vitro 
 
The third factor that was investigated in more detail during the work for this thesis 
was the basic helix-loop-helix (bHLH) transcription factor 4 (TCF4, also called: ASP-
I2, bHLHb19, E2-2, E2.2, ITF-2, ME2, MITF-2, SEF-2, and TFE). The Tcf4 gene 
encodes two major protein isoforms: a short one with a length of 511 amino acids  
(TCF4b) and a long one with a length of 670 amino acids (TCF4a). These isoforms 
result from alternative promoter usage. Both of them share the bHLH domain at the 
carboxy-terminus, however the shorter isoform, TCF4b, is lacking a domain located 
within the amino-teminal region, which seems to be important for the inhibitory 
transcriptional activity reported for TCF4 (Skerjanc, Truong et al. 1996).  
A 
B 
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Furthermore, this gene was of interest to us as it has been reported previously that 
expression of the longer isoform, TCF4a, responds to β-catenin signaling (Kolligs, 
Nieman et al. 2002). The original in-situ probe as well as the RT-PCR primers used in 
my secondary screens were however not isoform specific. Given the previous 
observations by Kolligs and colleagues on the human and rat Tcf4 promoters, we 
concentrated for our promoter studies on the putative promoter region of the longer 
Tcf4a transcript. Within the 2,3 kb up-stream region of the transcriptional start of 
mouse Tcf4a a total of 35 putative Tcf/Lef binding sites were identified using 
bioinformatic analysis. 
The luciferase assay showed no significant up-regulation upon co-transfection of 
TCF1/β-catenin. In contrast an up to 2,5-fold increase in luciferase activity was 
observed upon co-transfection of increasing amounts of Lef1/β-catenin expression 
vectors. These results suggest that the longer isoform of Tcf4a is also inducible by 
canonical Wnt-signaling in the mouse (Fig. 21). 
 
 
 
Fig. 21: Predicted Tcf1/Lef1 binding sites on the Tcf4a promoter (A). Luciferase-assay 
with the reporter-construct shown in (A) and increasing amounts of Tcf1/β-catenin or 
Lef1/β-catenin (B). 
 
In order to address the question whether Tcf4 might serve as factor X in the 
regulation of Sox9 I performed luciferase assays co-transfecting an expression 
plasmid carrying the ORF of the long Tcf4 isoform (TCF4a) and the Sox9-luciferase 
reporter construct. Again based on my bioinformatical analysis using the Uniprobe 
B 
A 
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database 7 putative binding sites for TCF4, which has been shown to bind to the E-
box motive CANNTG via its bHLH domain, were predicted to be present in the 2,9 kb 
Sox9 promoter region. bHLH-proteins have been reported to mediate transcriptional 
activation as well as repression and as these proteins are known to act as dimers it is 
thought that this differential activity depends on the combination of binding partners. 
A dose dependent decrease of the luciferase activity was observed in these co-
transfection assays (Fig. 22). Thus implicating the β-catenin regulated TCF4a protein 
as a potential negative regulator of Sox9 at least in vitro. 
 
 
 
Fig. 22: Predicted Tcf4 binding sites on the Sox9 promoter (A). Luciferase-assay with 
the reporter-construct shown in (A) and increasing amounts of Tcf4a expression 
vector (B). 
 
 
2.2.3.4 Tcf1 but not Lef1 has an additive effect on Tcf4a mediated Sox9 
repression in vitro 
 
Based on the previous observations that activation of β-catenin results in repression 
of Sox9 expression, but up-regulation of Tcf1 and Lef-1 in the limb mesenchyme (Hill, 
Spater et al. 2005; Hill, Taketo et al. 2006) the possibility that a Tcf/β-catenin 
complex could directly mediate repression on the Sox9 promoter had also been 
investigated in our lab. Ongoing work by other lab members revealed that the 
canonical pathway, in particular acting through Tcf1 might have the potential to 
repress Sox9 at least in vitro.  
A 
B 
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To investigate a potential additive effect between the transcription factors acting 
down-stream of canonical Wnt-signaling and being positive targets thereof and the 
bHLH factor TCF4 on the Sox9 promoter, I carried out luciferase reporter assays co-
expressing a constant amount of either Lef1 or Tcf1 in addition to increasing amounts 
of TCF4a.  
 
 
Fig. 23: Luciferase Assay with stable amount of TCF4a and increasing amounts of 
Lef1. 
 
No statistically significant additional repressive effect was observed upon co-
treatment with increasing amounts of TCF4a together with constant levels of Lef1 
(two-tailed t-test) (Fig. 23).  
In contrast addition of increasing amounts of TCF4a together with constant amounts 
of Tcf1 resulted in a statistically significant difference in the repressive effect for the 
highest concentration of Tcf4a (1µg), when compared to either Tcf4a or Tcf1 alone 
(Fig 24). This suggests an additive repressive effect of these two factors on the Sox9-
promoter.  
 
 
Fig. 24: Luciferase Assay with stable amount of Tcf4a and increasing amounts of 
Tcf1 on the Sox9-promoter. 
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It would be interesting to perform similar combinatorial experiments with these factors 
using a lower concentration for Tcf1, as 0,5 µg already resulted in a repression that 
was stronger than the combination of the factors at concentrations of 0,25µg and 
0,5µg for Tcf4a, as such potentially masking a combinatorial effect at lower 
concentrations. 
To investigate if addition of β-catenin has a positive effect on this repression the 
same experiment was carried out using a Tcf1/β-catenin fusion protein, as using this 
fusion protein a more pronounced repressive effect compared to Tcf1 or Tcf1 in 
combination with β-catenin had been observed. Unfortunately this experiment could 
not be interpreted (Fig. 25) as the fusion protein alone resulted in a strong repression 
at the concentration of 0.0625 µg. Thus in future experiments even lower 
concentration for the Tcf1/β-catenin fusion protein should be used.  
 
 
Fig. 25: Luciferase Assay with stable amount of Tcf4a and increasing amounts of 
Tcf1/β-catenin fusion protein on the Sox9-promoter. 
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2.2.4 Overexpression of Tcf4a results in a limb phenotype 
 
A transient transgenic approach was used to investigate the function of Tcf4a in limb 
development with a particular focus on chondrogenesis in vivo. For this I had cloned 
the cDNA of Tcf4a into a backbone vector containing as upstream elements a 
chicken insulator, a 3 kb Prx1 promoter region and as down-stream elements an 
SV40 poly A (Logan, Martin et al. 2002). The construct is shown in Fig. 26.  
 
 
Fig. 26: Construct used for limb mesenchyme specific overexpression. 
 
Similar constructs have also been generated for the other two genes, Irx5 and Fra2, 
which I had more closely examined during the course of this thesis in order to 
produce transient transgenic embryos to examine the in vivo function upon 
overexpression.  
Unfortunately, it had only been possible to do one round of pro-nucleus injections for 
the factor Tcf4a before the end of my thesis. From this one round I was able to 
retrieve 2 litters of 2 embryos each at E12,5 of embryonic development. Of the four 
embryos one showed an obvious morphological difference. By genotyping PCR I 
could confirm that this particular embryo was carrying the transgene (Fig. 27).  
 
 
Fig. 27: Genotyping of the embryos received upon pronucleus injections. 
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This result I got at the very end of my diploma thesis work. Therefore I was not able 
to carry out a detailed analysis of the transgenic phenotype. However, 
morphologically this embryo was reduced in its overall size and showed a limb 
phenotype (Fig. 28). The observed phenotype in the limb resembled grossly the limb 
abnormalities seen in the limb-specific Sox9 knock-out (Akiyama, Chaboissier et al. 
2002). This is what we would have expected from a factor, which is capable to 
repress Sox9 in the limb bud.  
 
Fig. 28: Right (A) and left (B) view of the transgenic embryo and its WT-littermate. 
Magnifications of the limb region of the transgenic embryo (C=right, D=left) and WT-
litterate (E).  
 
In addition, I noticed upon further inspection of the transgenic embryo that there were 
phenotypic differences with respect to the left and right site of the body (Fig 28 A, B, 
C, D). This may be due to differential expression of the transgene, which is known to 
occur in founder mice. The most interesting phenotypic feature was that digit 
condensations were strongly reduced. Condensations were visible in the right 
forelimb (Fig. 28C) but almost no condensations were visible in the left fore- and 
hindlimbs (Fig. 28D). In contrast in the limbs of the wild-type embryo condensations 
were clearly developed at E12,5. Additionally, as the Prx1 promoter also drives 
expression in the head mesenchyme a phenotypic difference was visible in the shape 
of the head. However, since the sample size was only n=1 this observations have to 
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be taken with caution and would have to be confirmed through the generation of 
additional transgenic animals showing a similar phenotype. This would also allow to 
establish whether overexpression of Tcf4a negatively affects Sox9 expression and to 
examine its potential role limb development. 
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3 Discussion 
 
3.1 CyclinD1 but not Tcf7l2 is negatively regulated by Wnt/β-
catenin-signaling in vitro and in vivo 
 
Previously it has been observed by performing in-situ hybridizations on sections 
through the limb buds of Prx1-Cre conditional β-catenin LOF or GOF embryos that 
cyclinD1 and Tcf7l2 expression was altered. Particularly the results from the GOF 
limbs suggested that both genes might be negatively regulated by stabilization of β-
catenin. However, a negative regulation could only be confirmed in the case of 
cyclinD1 using luciferase-promoter studies. This is particularly interesting as cyclinD1 
has been described to be a direct, positively regulated target of Wnt/β-catenin 
signaling in human colon cancers (Tetsu and McCormick 1999); (Shtutman, 
Zhurinsky et al. 1999). However, the notion that cyclinD1 is a direct target has been 
challenged recently (Terauchi, Tsuji et al. 1999). My in vitro promoter studies would 
suggest that its expression can even be repressed by a β-catenin/Tcf complex, which 
is in agreement with the in vivo observations by previous lab members. Thus in order 
to show that cyclinD1 is indeed a direct target of the β-catenin pathway in the limb 
mesenchyme, ChIP-experiments using Lef1-, Tcf1-, and β-catenin antibodies with 
primary material from mouse limbs would have to be performed in order to provide 
evidence that these factors bind to the cyclinD1 promoter in the limb. Such 
experiments are currently on their way in our lab. 
As the canonical Wnt-signaling so far has been primarily described as being an 
activatory pathway of gene expression additional experiments would have to be 
carried out in order to understand the mechanism how a repressive effect is 
achieved.  
In the case of Tcf7l2 the in vitro promoter studies clearly show that Tcf7l2 is positively 
regulated by a β-catenin/Tcf or Lef complex. This is in contrast to what has been 
observed in vivo. However, the discrepancy might be due to a suppression of cell-
fate in the limbs upon stabilization of β-catenin, as a number of other genes have 
been shown to be deregulated in these limbs (Hill, Taketo et al. 2006). 
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3.2 Target Genes of Wnt-signaling in limb bud development 
 
From the transcriptome analysis screens carried out using limb bud cells and 
chondrocytes I could confirm a total of 10 genes out of the 53 genes, which I had 
analyzed further. So together with the 5 genes previously confirmed in our lab in total 
15 out of 58 genes, which were deregulated based on the microarray analysis, could 
be confirmed by in-situ hybridization and/or RT-PCR to have a higher expression 
level in β-catenin GOF limbs than in limbs of wild-type embryos. The ones identified 
by me were components of intracellular pathways, such as the BR serine/threonine 
kinase 1 (Brsk1), the Protein kinase C beta 1 (Prkcb1), the Phosphatidylinositol 3-
kinase regulatory subunit 1 (Pik3r1), the Adenylate cyclase inhibiting G-alpha protein 
(Gnai1), transcription factors such as Irx5, Runx1, Tcf4, Foxo3a, Fra2, and 
components of the Wnt-pathway, such as the Wnt-inhibitory factor 1 (Wif1). With the 
exception of Wif, none of the other genes had been described as a target of Wnt-
signaling up to now (http://www.stanford.edu/~rnusse/pathways/targets.html). For the 
the kinase or kinase-related genes Brsk1. Prkcb1 and Pik3r1 knock-out mice are 
described in the literature, but no skeletal abnormalities have been reported in these 
mice (Leitges et al., 1996; Kishi, Pan et al. 2005, Fruman, Snapper et al. 1999; 
Terauchi, Tsuji et al. 1999; Chen, Mauvais-Jarvis et al. 2004). The Prkcb1 expression 
pattern is very interesting, as it appears to be restricted at least at early stages of 
limb development to the future carpal region (see Fig. 13). If it is indeed the carpal 
region would have to be further investigated and it would be interesting to see what 
the expression looks like at later stages. Nevertheless its early expression pattern 
excludes it as a potential factor X, since this factor should be expressed similarly to 
the transcription factors Tcf1 and Lef1 in the sub-ectodermal mesenchyme of the 
early limb bud. Pik3r1 is a modulator of the phosphatidylinositol 3-kinase (Pik3), 
which is a central intracellular signaling component. It has so far been implicated to 
play a functional role in osteoclast maturation, but not in chondrogenesis/ostegenesis 
(Munugalavadla, Vemula et al. 2008). Knock out mice were not documented to show 
a skeletal phenotype (Fruman, Snapper et al. 1999; Terauchi, Tsuji et al. 1999; Luo, 
McMullen et al. 2005); however the PIK3 pathway has been shown to be linked to 
Wnt-signaling via activation of GSK3 (Naito, Akazawa et al. 2005). Of interest is also 
the observation that Pik3r1 can interact with β-catenin and increase its activity as a 
transcriptional cofactor (Espada, Peinado et al. 2005).  
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For the inhibitory G alpha subunit Gnai1 only few studies have been published yet, 
primarily focusing on a neurobiological context and for the targeted knock-out no 
skeletal phenotype has been described (Pineda, Athos et al. 2004; Kishi, Pan et al. 
2005). The same is true for Brsk1 which also was investigated in a neurobiological 
context and where for targeted knock outs no skeletal phenotype was described 
(Kishi, Pan et al. 2005). 
Of the transcription factors Foxo3a can probably be ruled out as acting as factor X 
since its expressed in the wild-type limb in a pattern congruent to Sox9 (Fig 16). 
Furthermore, I could not detect a broad upregulation by in-situ hybridization only by 
RT-PCR. But Foxo3a could in principle still be involved in the modulation of Sox9 
expression in a positive or negative fashion or play a role in skeletogenesis in a 
different way. In support of the latter a recent publication using chondrocyte specific 
expressed constituvely active or dominant negative Akt has implicated a role for 
Foxos in skeletogenesis acting downstream of Akt signaling to promote chondrocytes 
proliferaton (Rokutanda, Fujita et al. 2009). However such a role in skeletogenesis is 
not supported the Foxo3a knock-outs, where no skeletal phenotype has been 
reported (Castrillon, Miao et al. 2003; Hosaka, Biggs et al. 2004). This could be due 
to redundancy between Foxo1, Foxo3a and Foxo4 as they show overlapping 
expression (Furuyama, Nakazawa et al. 2000) and are regulated by Akt (Brunet, 
Bonni et al. 1999). 
Another factor implicated by the transcriptome analysis and confirmed in in-situ 
hybridisation and RT-PCR was Runx1. It has been shown to promote chondrocytic 
differentiation (Wang, Belflower et al. 2005) and was shown to have similar 
expression pattern as Runx2 in chondroprogenitors of the axial skeleton (Smith, 
Dong et al. 2005). Interestingly, Runx2 has already been shown to be a target of 
Wnt-signaling in chondrocytes (Dong, Soung do et al. 2006). Further investigations 
as Luciferase assays and ChIP experiments could be used to establish if Runx1 is 
also regulated by Wnt-signaling. 
Eya3 was another transcription factor implicated by the primary screen; however the 
secondary screens did not show a differential expression. What makes this factor 
interesting is that section in-situ hybridisations revealed strong subectodermal 
expression in the wild-type limb (see Fig. 16). This makes it a candidate to be 
regulated by Wnt/Fgf as proposed in the model by ten Berge and colleagues (ten 
Berge, Brugmann et al. 2008). Real-time PCR would be sufficiently sensitive to 
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exclude a regulation by canonical Wnt signaling. Interestingly the Eya3 knock-out 
mice showed a phenotype with decreased bone mineral content and shorter body 
length (Soker, Dalke et al. 2008), but so far no further studies are published 
investigating the underlying mechanisms for this effects. 
As the remaining transcription factors Fra2, Irx5 and Tcf4 have been investigated in 
further detail they are discussed more extensively in the following. 
 
3.3 Fra2 is probably not directly regulated by canonical Wnt 
signaling 
 
Fra2 in the wild-type was not significantly expressed in the limb bud mesenchyme 
and was only up-regulated in some distal patches upon stabilization of β-catenin. The 
up-regulation was further confirmed by RT-PCR. However, on the basis of the Fra2 
luciferase reporter assay I would conclude that it is probably not a direct target of the 
canonical Wnt-pathway, although I can not completely rule it out, given that the 
promoter we tested is only a 1,9 kb region and additional TCF/LEF binding site were 
present in the up-stream region of this construct. Despite the local restricted up-
regulation we had decided to have a closer look at Fra2, particularly as other 
members of the AP1 complex have been indicated as target gene of Wnt-signaling 
(Mann, Gelos et al. 1999). Furthermore Fra2 was of interest as it already has been 
shown as a factor in chondrogenesis (Karreth, Hoebertz et al. 2004). 
 
3.4 Irx5 is upregulated by canonical Wnt-signaling and can repress 
Sox9 in vitro 
 
In in-situ hybridizations the Iroqouis box transcription factor, Irx5, showed a clear 
upregulation in β-catenin GOF limbs (Fig. 14). This was furthermore confirmed by 
luciferase reporter assays that showed Lef1/Tcf1 plus β-catenin to be sufficient to 
induce transcription from a 1,9kb part of the Irx5 promoter. Section in-situ 
hybridizations of wild-type limb showed a pattern of subectodermal expression (Fig. 
16 B) in addition to the proximal expression domain (Fig. 16 A) that was already 
documented by Houweling and colleagues (Houweling, Dildrop et al. 2001). As Wnts 
are thought to be secreted from the ectoderm – this subectodermal expression 
together with the upregulation upon β-catenin stabilization and luciferase assays 
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presents good evidence that Irx5 may be activated by β-catenin/Wnt signaling during 
limb development. 
Yet among the mammalian Irx genes Irx3 has been shown to be inducible by Wnt3a 
in neural tissue (Braun, Etheridge et al. 2003). Interestingly Irx3 has an overlapping 
expression pattern to Irx5 in the developing brain as well as in limb buds (Houweling, 
Dildrop et al. 2001). Further support for the observation that Wnt-signaling could 
activate Irx transcription factors comes from Gomez-Skarmeta and colleagues who 
observed an upregulation of the Xenopus Irx homolog Xirx1 when they injected a 
dominant negative form of Gsk-3 or wild-type β-catenin into the animal pole of 
Xenopus embryos (Gomez-Skarmeta, de La Calle-Mustienes et al. 2001).  
In addition we tested the effect of Irx5 on Sox9 expression. These luciferase assays 
showed a strong repressive effect of Irx5 on the 2,9kb Sox9 promoter construct. The 
repressive effect is not entirely surprising as Irx proteins have been described to act 
primarily as transcriptional repressors (Gomez-Skarmeta, de La Calle-Mustienes et 
al. 2001; Kudoh and Dawid 2001; Itoh, Kudoh et al. 2002; Matsumoto, Nishihara et 
al. 2004) and only rarely as activators (Bao, Bruneau et al. 1999; Matsumoto, 
Nishihara et al. 2004). 
Irx3 and Irx5 overlap in their expression pattern in the limb. A similar situation was 
observed in different tissues also for the other paralogue gene pairs of the cluster 
Irx1/Irx2 and Irx4/Irx6 (Houweling, Dildrop et al. 2001). This indicates that they share 
enhancers for the same tissues and due to their high conservation could functionally 
replace each other (Cavodeassi, Modolell et al. 2001; Houweling, Dildrop et al. 
2001). 
So far only Irx2, Irx4 and Irx5 targeted knock outs have been published. Irx5 knock-
out mice showed aberrances in the nervous system, eyes and reduced size but a 
skeletal patterning defect has not been documented (Cheng, Chow et al. 2005). Due 
to the overlapping expression patterns of Irx3 and Irx5 a study of their function may 
require an Irx3/Irx5 double knock-out. In general the study of Irx genes in the limb 
would be very interesting as they show a very well defined pattern during limb 
development (Houweling, Dildrop et al. 2001) and are proposed to be important for 
the determination of developmental territories (Cavodeassi, Modolell et al. 2001). To 
our knowledge no comprehensive studies of Irx gene functions in limb development 
are published. 
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3.5.1 Tcf4 is positively regulated by Wnt/β-catenin and represses 
Sox9 in vitro  
 
As described above Tcf4 encodes for 2 major isoforms Tcf4a and Tcf4b. An isoform 
unspecific in-situ probe indicated a clear upregulation upon β-catenin stabilization 
(Fig. 13). Section in-situ hybridization revealed that the wild-type expression is 
restricted to subectodermal regions of the developing limb (Fig. 16 A). This pattern is 
to some extent congruent to the region under influence of subectodermal Wnts as 
proposed in the model by tenBerge et al (see Fig. 5). 
As in the literature Tcf4a had already been suggested to be a direct target gene of 
Wnt-signaling (Kolligs, Nieman et al. 2002) all further investigations were focused on 
this longer isoform. In luciferase assays using a 2,3kb part of the Tcf4a promoter we 
could confirm Tcf4a as a potential direct target gene of Wnt signaling.  
More interestingly, overexpression of Tcf4a was able to repress luciferase expression 
driven by the 2,9kb Sox9 promoter, showing that Tcf4a has the potential to repress 
Sox9 in vitro; however this effect was less significant then for Irx5. This repressive 
effect is in concordance with previous studies that described Tcf4a as a factor 
involved in gene repression depent on its binding partner (Skerjanc, Truong et al. 
1996; Petropoulos and Skerjanc 2000). As a slight additive repressive effect of Tcf4a 
in combination with Tcf1 was observed it is possible that in the limb Tcf4a in 
combination with Tcf1 might act in the repression of Sox9. This would have to be 
established in further in vitro and in vivo studies in order to assess the biological 
relevance of this finding.  
 
3.5.2 Tcf4a overexpression leads to a limb phenotype 
 
To investigate the in vivo function of Tcf4a the generation of transient transgenic 
embryos was planned. As described one transgenic embryo was obtained, which 
showed a limb phenotype but due to end of the diploma work I was not able to carry 
out any further analysis of the transgenic embryo or to reproduce the result. 
However, in-situ hybridizations that were carried out by Hermann Novak in the mean-
time on limb sections of this embryo revealed that Sox9 and Col2aI levels did not 
show a significant downregulation, which one would have expected if Tcf4a is a 
negative regulator of Sox9. Therefore these preliminary results suggest that Tcf4a 
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can most likely be excluded to act as an inhibitor of Sox9 on its one. However, there 
is still the possibility that Tcf4a together with another transcription factor, which is up-
regulated upon stabilization of β-catenin, represses Sox9.   
A possible explanation for the observed phenotype could be the inhibition of cell 
proliferation. Support for this hypothesis comes from a recent study by Herbst and 
colleagues, which found that Tcf4a and Tcf4b can act as p53 independent positive 
regulators of the cell cycle inhibitor p21 in colon cancer cell lines (Herbst, Bommer et 
al. 2009; Herbst, Helferich et al. 2009). This would stand in contrast to the model by 
tenBerge et al. as Tcf4a is expressed in the proliferative region of the wild-type limb 
bud (Fig. 3). However; the growth retardation also could be due to secondary effects 
of the overexpression and would need to be reproduced. 
Targeted knock outs of Tcf4 have so far not revealed skeletal patterning defects 
(Zhuang, Cheng et al. 1996; Bergqvist, Eriksson et al. 2000). Nevertheless Tcf4 is 
potentially involved in skeletogenesis, as in the human Pitt-Hopkins Syndrome, which 
is caused by mutations in the Tcf4 gene, aberrant thumb morphology has been 
observed in some cases. Additionally many patients suffer from a small stature (de 
Pontual, Mathieu et al. 2009).  
 
In summary it can be concluded from the work presented that Tcf4 most likley is a 
target gene of Wnt-signaling in limb development and that its overexpression leads to 
a strong phenotype. Further studies will be necessary to reveal the functional details. 
In future work it will be important to carry out assays discriminating between the two 
isoforms. Another potential challenge in revealing the TCF4 function in limb 
development is that bHLH-factors often act as heterodimers and that the identification 
of its putative limb mesenchyme specific binding partner(s) is all but a trivial task. 
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4 Material and Methods 
 
 
4.1 Solutions and Buffers 
 
BM Purple AP substrate (Roche) 
 
50x Denhardt’s: 1% (w/v) Ficoll 400 
 1% (w/v) Polyvinilpyrrolidone 
 1% (w/v) BSA 
 in MPW 
 Filter and store at –20 °C.  
 
Glycerol Mounting Medium (Dako) 
 
2X HBS: 8g NaCl 
 0.2g Na2HPO4-7H2O (0.14g if using dihydrate; 
[phosphate] must be 1.5 mM) 
 6.5 g HEPES 
 pH to 7.05 and bring up to 500 ml with distilled water. 
 Aliquot and store at –20°C. 
 
HISS Sheep Serum, heat inactivated at 56C for 30’.  
 store at –20 °C 
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Hybridization solutions 
Section In-situ: 10mM Tris pH7.5 
 600mM NaCl 
 1mM EDTA 
 0.25% SDS 
 10% Dextran Sulfate 
 1x Denhardt’s 
 200ug/ml yeast tRNA(Gibco) 
 50% formamide 
 Store at –20°C 
 
Whole mount ISH: 50% Formamide 
 5x SSC, pH 4.5 (stock: 20x) 
 50 µg/ml tRNA (stock: 10mg/ml)  
 1% SDS (stock 10%) 
 50 µg/ml heparin (stock: 100mg/ml) 
 store at -20°C 
 
2x MABT: 200mM Maleic Acid 
 300mM NaCl 
 add 10M NaOH to adjust pH to 7.5 
 0.2% Tween-20 
 
MPW-DEPC: Add 1ml DEPC/1l MPW, incubate oN and autoclave 
 
NTMT pH9.5: 100mM NaCl 
 100mM Tris pH9.5 
 50mM MgCl2 
 0.1% Tween-20 
 
10 x PBS: 1.37M NaCl 
 27mM KCl 
 100mM Na2HPO4 
 20mM KH2PO4 in MPW 
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PBS-DEPC: 100ml 10x PBS + 900ml MPW-DEPC 
 
PBT: 1X PBS + 0.1% (section) or 1% (whole mount) Tween 
 
10xSSC: 3M NaCl 
 0.3M sodium acetate 
 pH to 7.0 (NaOH) 
 
20x SSC pH 4.5: 6M NaCl 
 0.6M sodium acetate  
 adjust pH 4.5 with citric acid 
 
Solution I: 50% Formamide 
 5x SSC, pH 4.5 
 1% SDS 
 
Solution III: 50% Formamide 
 2x SSC, pH 4.5 
 
10x TAE:  4mM Tris-acetate 
 1mM EDTA pH 8.0 
 
10x TBE: 1M Tris base 
 880mM Boric acid 
 40ml 0.5M EDTA (pH 8) 
 
1X TBS:  50 mM Tris.HCl, pH 7.4  
 150 mM NaCl 
 
TBST: 1X TBS 1% Tween 
 
1x TE: Tris-EDTA-Buffer, pH 8.0 
 
10xTEA: 1M Triethanolamine pH 8.0 
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10X TNE Buffer: 100mM Tris 
 2.0M NaCl 
 10mM EDTA; pH 7.4 
 
Yolk Sac Buffer:  50 mM Tris (pH 8.0) 
 100 mM EDTA 
 0.5% SDS 
 1.6 µl of fresh 10 mg/ml Proteinase K 
 
Media 
 
DMEM High Glucose (in house) + L-Glutamine, Penicillin/Streptavidin, 10% Foetal 
Bovine Serum, + 1% non-essential Amino-Acids 
 
LB: Add the following to 800ml H2O: 
 10g Bacto-tryptone. 
 5g yeast extract. 
 10g NaCl. 
 Adjust pH to 7.5 with NaOH. 
 Adjust volume to 1L with dH2O 
 Sterilize by autoclaving 
 
 
Mouse Strains 
To obtain conditional β-catenin gain-of function mice (β-cat∆ex3Prx1/+) Prx1-Cre 
females (Logan, Martin et al. 2002) were crossed with homozygous exon3 floxed β-
catenin females (Harada, Tamai et al. 1999). Embryos were identified by visible 
changes in the limb morphology. 
 
 
293T Cell Line: 
293T is a modified human embryonic kidney cell line that contains the SV40 large T-
Antigen, which allows replication of plasmids containing the SV40 origin. (Graham, 
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Smiley et al. 1977). Cells are cultured in the high glucose DMEM media as described 
above at 37 °C, 5% CO 2. Cells were split 1:20 when confluent (about every 4 days). 
 
4.2 Analysis of Affymetrix Gene Expression Data 
 
Data Analysis was carried out by use of Microsoft Access. P-values of 0,01-0,05 
which are usually used for this kind of analysis only gave very few candidate genes 
therefore the threshold for the p-value was set to <0,2. The threshold for the 
logarithmic fold change was set to >0,4 to include also genes that are close 0,5. 
These parameters were applied to the combined datasets of Affymetrix Lyashenko 
GOF14h/Kostanova GOF24h and Lyashenko GOF14h/LOF36h, respectively. These 
results were then filtered for genes with a putative function in cell-signaling or 
transcriptional control by connecting the Affymetrix IDs to the Gene Ontology 
Molecular Function Database (Ashburner, Ball et al. 2000) and using a query for the 
terms: transcript* (*=transcriptional activator, transcriptional inhibitor, transcriptional 
regulator etc), Kinase, Phosphatase, GTP, GEF. 
 
4.3 In-situ Hybridizations 
 
Template Generation 
 
Most In-situ probes used in this work could be created by using the corresponding 
clones from the Riken library provided by the IMP-Biooptics department. The cDNA-
sequences were obtained from ENSEMBL.org (Hubbard, Aken et al. 2009), and 
suitable Riken clones were identified by Blast-search in the Fantom Riken online 
database (Maeda, Kasukawa et al. 2006). Importantly, it was avoided to include 
conserved domains for all the probes generated. Those were identified using the 
conserved domain database from NCBI (Marchler-Bauer, Anderson et al. 2009).  
 
A total of 14 probes with no corresponding clones in the Riken library, or for which 
Riken clone for other reasons could not be used were generated by PCR. For this 
purpose, cDNA from wild-type E15,5 whole embryo was used. Primers were 
designed to give products of 400-500bp using the Primer 3.0 program (Rozen and 
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Skaletsky 2000). Again the regions were checked for conserved domains. PCR-
conditions were equal to Semi-Quantitative PCR described below. Primer sequences 
are shown below. 
 
Stock # Gene Sequence 
HAR2066 Mobkl1a fw ATGAGCTTCTTGTTTGGTAGTCG 
HAR2067 Mobkl1a rev GTTTGTTCCATCTGCCCAGT 
HAR2068 Rims2 fw TCCTCCCTAGTAGATCCAACC 
HAR2069 Rims2 rev CTTTGCTAGGGCACAATGTG 
HAR2070 Abca9 fw GGAAGAGACACTTGAGACTGG 
HAR2071 Abca9 rev CCAGAAAGCCGACTCTCGA 
HAR2146 Gm967 fw ACCAGGAGCAGGAGTCTTCA 
HAR2147 Gm967 rev TTCATGAATGTCCGGAGTCA 
HAR2148 Flt4 fw CTGTACCTGCAGTGCGAGAC 
HAR2149 Flt4 rev CAGAGCTAACCCAGCAAAGG 
HAR2150 Abcb7 fw GGTGCCCTTACTGTTGGAGA 
HAR2151 Abcb7 rev CGAAGACTTTCCAGGCTCAC 
HAR2154 Pik3c2g fw CTGGCCAGGGTGAGTGTAAT 
HAR2155 Pik3c2g rev CGAAGAGCCGAGATGGATAG 
HAR2156 Dusp19 fw GGGAAGATGCCACAGTTCAT 
HAR2157 Dusp19 rev GGATTCGGACATATGGATGG 
HAR2158 Brsk1 fw TCGGGAATTTCATCTCCTTG 
HAR2159 Brsk1 rev GGCTCCGTTCTTCTCATCTG 
HAR2160 Mkl2 fw ACCCCAGCAGTTTGTTGTTC 
HAR2161 Mkl2 rev TGGAATGACTCAGCAAGTCG 
HAR2162 Foxd4 fw CTTGGGAGAGAGACCAGAGC 
HAR2163 Foxd4 rev TTAAAATTCGGGCAAGGTC 
HAR2164 Mdn1 fw GAGGAACCGTGGACTTGAAA 
HAR2165 Mdn1 rev GGACAACCGAGAGTCGAGAG 
HAR2220 p300 fw GAACGCCTCAGGAACAGGTA 
HAR2221 p300 rev CCCCTGATCATCTACCATGC 
HAR2222 Rerg fw TTGAAGATGCAACCACCAAA 
HAR2223 Rerg rev GTGAATTGCGGGTCTTGTTT 
 
The PCR-products were ligated into pGEM-T-easy (Promega) and sequenced to 
confirm their identity and to determine the orientation of the insert with respect to the 
backbone. Details on the template, restriction enzyme, polymerase and probe length 
are shown in the table below. 
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Gene Template Polym. Restriction 
enzyme 
Probe Length 
Abca13 A930002G16 T3 NdeI 469 
Abcb7 PCR Sp6 NcoI 428 
Abra C130068O12 T3 EcoRI 371 
Akap5 A830007p05 T3 CfoI 450 
Arl4c A930033L07 T3 XbaI 1kb 
Brsk1 PCR Sp6 NcoI 458 
CamK4 A730057B21 T3 HindIII 760 
Cdkn2b I920040F24 T3 CfoI 409 
Depdc2 A430104n04 T3 NcoI 421 
Dusp19 PCR Sp6 NcoI 466 
Epha3 B130048J04 T3 BglII 1kb 
Erbb4 F530209F06 T3 XhoI 367 
Etv4 G730044E08 T3 CfoI 1kb 
Eya3 G730019b10 T3 BglII 820 
Flt4 PCR Sp6 NcoI 422 
Foxd4 PCR Sp6 NcoI 431 
Foxo3a E130305O06 T3 NdeI 324 
Fra2(Fosl2) F730016C03 T3 NheI 1,1kb 
Gm967 PCR SP6 NcoI 450 
Gnai1 6330599a21 T3 NdeI 791 
Gyk 2010011F10 T3 NcoI 506 
Hoxb7 9230026O03 T3 BglII 288 
Irx5 1200013N09 T3 BglI 929 
Lhx6 C730046L05 T3 XbaI 860 
Lipn1 F630108j21 T3 SpeI 415 
Ly6g6e 2310011I02 T3 CfoI 900 
Mdn1 PCR Sp6 NcoI 455 
Mkl2 PCR T7 SalI 488 
Mobkl1a PCR T7 SalI 1,3kb 
Nr3c1 F830016H14 T3 HindIII 1,1kb 
Pcaf PCR SP6 NcoI 500 
Pik3r1 c53005k14 T3 Xba1 958 
Pik3c2g PCR T7 SalI 405 
Prkcb1 D230012a21 T3 EcoRI 920 
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Gene Template Polym. 
 
Restriction 
enzyme 
Probe Length 
Prps2 B130019b02 T3 HindIII 593 
Ptprn A530097K05 T3 CfoI 510 
Rabep1 6330437j23 T3 NheI 421 
Rerg PCR Sp6 NcoI 723 
Arhgap I920042B01 T3 BglII 1,4kb 
Rims PCR SP6 NcoI 650 
Runx1 G830041K20 T3 NheI 1,6kb 
Sgms1 C530027b15 T3 NcoI 1,1kb 
Srpk3 1200011B22 T3 NcoI 1,3 
Tcf4 Har 1025 T3 BglII 603 
Tcf23 5031411E05 T3 BamHI 534 
Utf1 2410026A04 T3 NheI 1,1kb 
Wif1 HAR987 SP6 XhoI 500 
 
From these templates 10 µg of DNA each were digested for 2h at 37 °C in a vo lume 
of 100µl with the appropriate enzyme (see table above) and restriction buffer to 
linearize the plasmid. After a phenol-chloroform extraction (1/10 Volume 3M NaAc pH 
5,4 and 1 volume PCI-Mix pH 8) the aqueous phase was transferred into a new tube 
and DNA precipitated with 100% EtOH. After centrifugation the pellet was washed 
with 70% EtOH, dried, and resuspended in 10 µl MPW. Prior to precipitation 1µl of 
the template was checked on a gel to control the completeness of the digestion. 
 
 
Probe preparation  
 
From 1µg of the linearized DNA the RNA probe was prepared by addition of a mix of 
2µl DIG-labeled nucleotide mixture (Roche), 2µl 10x Transcription Buffer (Roche), 
0,5µl RNase inhibitor and 13µl MPW. Finally 1,5µl of the appropriate RNA-
polymerase (as indicated in the table above) were added and the mix was incubated 
for 2h at 37 °C. 1 µl of the product was checked on a TBE-gel. The DNA-template 
was digested by adding 1µl DNase (Roche) and incubated for 15’ at 37 °C. The  RNA 
was then purified by LiCl/EtOH precipitation: 1µl Glycogen (Roche), 8µl LiCl-DEPC 
(5M), 100µl 1M TE-DEPC pH 8, 300µl EtOHabs (-20 °C) were added to the RNA. 
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Precipitation was incubated for 1h or over night at -20 °C. After washing with 70% 
EtOH-DEPC to remove excess salt on the next day the pellet was dried and 
resuspended in 100 µl MPW-DEPC.  
 
Section In-situ Hybridisations 
 
Embedding 
 
Embryos were dissected in PBS and fixed over night in 4% PFA/PBS at 4 °C. 
Embryos were then washed 2 times in PBS for 10 min and afterwards dehydrated in 
a series of ethanol (25% EtOH/PBS, 50% EtOH/PBS, 75% EtOH/MPW, and 100% 
EtOH) for 10 min each. The embryos were either stored at -20 °C or directly 
processed. For the transfer they were incubated in 100% EtOH for 1 hour and then 
cleared in Xylene two times for 10-30 minutes. Afterwards embryos were incubated in 
a 1:1 mix of Xylene/paraffin for 30 minutes at 60 °C, then for 3 times for 1 hour in 
paraffin at 60 °C. The last step can also be elonga ted to overnight. The samples 
were then ready for embedding and cutting. Sections were cut on a microtome in 
5µm sections.  
 
Hybridisation & Staining 
 
The slides were dewaxed by incubating them two times for 5’ in Xylene and 
afterwards were rehydrated by incubation in an EtOH/PBS-DEPC dilution series from 
100% to 25% and finally PBS-DEPC (each for 5’). The sections were fixed with 4% 
PFA/PBS (10’), washed with PBT-DEPC (1x rinsed then incubated two times for 5’) 
and treated with ProteinaseK for 10’ (20µl from 10mg/ml in 200ml PBS-DEPC). After 
two washing-steps with PBT-DEPC for 5’ each, the slides were fixed again with 
4%PFA/PBS for 5’, washed with PBT-DEPC (1x rinsed, then two times 5’) and 
afterwards acetylated by incubating them in 250ml of 0,1M TEA with 625µl Acetic 
Anhydride. The slides were then washed 3 times with PBT-DEPC (1x rinsed then two 
times 5’) and dried in the oven at 50 °C.  
1µl of the DIG labelled probe was mixed with 100µl hybridization solution/slide and 
incubated at 85°C for 3’ to solve secondary structu res. The mix was then pipetted on 
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the slides and a coverslip was put on. Afterwards the hybridisation cassettes 
containing the slides were incubated over night at 65 °C. 
After the hybridization the coverslips were removed from the slides by rinsing them in 
5x SSC then the slides were put in 1x SSC/50% Formamide for 30’ at 65 °C. As the 
next step the slides were incubated with TNE for 10’ and treated with TNE+RNase A 
(20 µg/ml) for 30’ at 37 °C. Subsequently they were tran sferred in TNE and incubated 
for 10’ at 37 °C followed by a 2x SSC and two 0,2 S SC incubations for 20’ at 65 °C 
each.  
Slides were then incubated two times in MABT for 5’ at RT. For blocking a 20% 
HISS/MABT-mix was applied to the slides for 1h at RT. Afterwards the slides were 
incubated with α-DIG-AB (1:2000 Roche) in 2% HISS/MABT at 4 °C over  night in a 
humidified box. 
The next day slides were rinsed in MABT, washed three times for 5’ each in MABT 
and then incubated with NTMT pH 9,5 for 10’ at RT. BM-Purple AP substrate (Roche) 
was added for detection. The staining progress was observed following the color 
reaction by regular checks on the microscope. When sufficient staining was achieved 
slides were rinsed in NTMT pH 9,5 and washed two times in PBS for 5’ at RT. For 
post-fixation slides were incubated with 4%PFA/PBS for 10’ and then rinsed in PBS 
and dH2O. DAKO-Glycergel was used for mounting. 
 
Whole-Mount In-situ Hybridisations (WM-ISH) 
 
For the WM-ISH embryos between E11.5 and E12 were used. With respect to the 
ex3 fl/fl mouse colony, I divided the embryos into two halves to be able to use 2 
probes using only embryo, since there was a heavy demand for these embryos/mice 
in our lab. 
After the harvest embryos were fixed in 4% PFA and on the next day dehydrated in a 
series methanol/PBT (25%, 50%, 75% 100% Methanol 5’ each). Embryos were 
stored until usage at -20 °C.  
Whole mount staining procedure was carried out using glass scintillation vials. At the 
beginning of the procedure embryos were rehydrated in the reversed series of 
methanol/PBT used for dehydration. Embryos were then washed in PBT two times 
for 5’. For bleaching they were incubated with 6% H2O2/PBT for 1 hour at room 
temperature.  
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After the bleaching embryos were again washed 3 times in PBT for 5’ and then 
treated with ProteinaseK to improve their permeability in the staining procedure. The 
length of the treatment is dependent on the stage of the mouse embryos. For the 
stage of E11.5 treatment of 15’ is recommended, but depends on the activity of the 
batch of ProteinaseK. For detection of ectodermally expressed genes its advisable to 
reduce length of treatment. Treatment was carried out using a concentration of 
10µg/ml ProteinaseK in PBT. To stop the ProteinaseK digest embryos were 
incubated for 10’ in 2mg/ml glycine in PBT. Followed by two washing steps with PBT 
for 5’. before re-fixation of embryos with 4%PFA/0,2% glutaralaldehyde in PBT for 
20’, which was followed again by two washing steps in PBT for 5’ each.  
Subsequently embryos were incubated for 10’ in a 1:1 mix of hybridisation solution 
and PBT. Then the embryos were incubated for another 10’ in hybridisation solution 
at room temperature before the pre-hybridisation at 70 °C for 1 hour. For 
hybridisation 1ml of hybridisation solution was mixed with 5µl of the DIG-labeled RNA 
probe and embryos were incubated over night at 70 °C.  
To wash away unspecifically bound RNA probe three washing steps for 30’ at 70 °C 
in solution I and three washing steps in solution III were carried out for 30’ at 65 °C 
each. The embryos were then washed 3 times for 5’ in TBST.  
While the washing steps were carried out, a preabsorption mix for the antibodies was 
prepared. Herefore mouse embryo powder - app. 5mg/500µl TBST and 500µl 
TBST/In-situ reaction – was incubated on a heatblock at 70 °C a nd 700rpm. The mix 
was then cooled on ice and 10µl HISS, 1µl anti-DIG antibody, 200µl BM blocking 
reagent and 290µl TBST were added per 500µl embryo powder solution and 
incubated for 1h at 4 °C. The mix was then centrifu ged for 4’ at 8000rpm to separate 
embryo powder from the supernatant. The supernatant from all Eppendorf tubes was 
then pooled and 200µl HiSS, 400µl BM blocking reagient and 1400µl TBST were 
added per 500µl of the initial volume. This leads to a total volume of 2ml/In-situ vial 
with an antibody dilution of 1:2000. 2ml of this mixture were added to the embryos 
after the last TBST washing step and vials were incubated over night at 4 °C.  
On the next day embryos were washed with TBST three times for 5’, 5-8 times for 
about 1h at room temperature and then overnight at 4 °C to reduce unspecifically 
bound antibody.  
For the staining reaction embryos were washed 3 times in NTMT for 10‘ and then 
incubated in BM Purple AP substrate in the dark. When the reaction was judged 
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complete by visual inspection embryos were washed twice in NTMT and twice in PBT 
for 5’ each, then post-fixed in 4% PFA/0,1% glutaraldehyde and stored in PBS. 
4.4 Total RNA-Isolations from embryonic mouse limb buds 
 
Embryos were harvested at E11.5 and limb buds dissected. PBS was sucked off, the 
tissue shock-frozen in liquid nitrogen and stored at -80 °C until further usage.  
0,2 ml Trizol were added and the tissue homogenized with a micro pistil in a 1,5 ml 
Eppendorf tube. After homogenization 0,8 ml of Trizol were added and the samples 
incubated for 5‘ at room temperature. After addition of 0,2 ml of chloroform and 
inverting for 15 sec the sample was again incubated for 2‘ and then centrifuged at 
4000 rpm, at 4 °C for 15 ‘. The upper layer was tra nsferred into a new tube and 0,5 
ml of isopropanol were added to precipitate the RNA. After 10’ incubation at RT the 
RNA was pelleted by centrifugation at 4000 rpm, 4 °C for 10‘. The pellet was then 
washed with 75% ethanol; vacuum dried and resuspended in DEPC treated water. 
To ensure complete resuspension tubes were incubated at 55 °C for 10‘ and 
afterwards the RNA quantified by photometer measurement.  
 
4.5 First Strand cDNA synthesis 
 
For synthesis of cDNA 1µg of total RNA was used. 1 µl of oligo dT (HAR 068; 
500ng/µl), 1µl dNTPs (10mM; Eppendorf) were used per reaction and dH2O was 
added to a volume of 10µl. To denature the RNA samples were heated at 65 °C  for 5‘ 
and cooled on ice for 5‘, then 4µl of 5X buffer FS (Invitrogen-Y00146), 2µl of 0,1M 
DTT (Invitrogen-Y00147) and 1µl of RNase inhibitor (Promega-N211A 16546404) 
were added, the samples mixed by pipetting and incubated at 42 °C for 2‘ before 1 µl 
of RT-superscript II (Invitrogen-C#18064-022) was added. The samples were then 
incubated for 50‘ at 42 °C. To inactivate the react ion, samples were heated for 15‘ at 
70 °C. 1 µl of RNaseH was then added and samples incubated for 20‘ at 37 °C to 
digest the RNA template strand. cDNA was stored at -20 °C until use. For all samples 
the –RT control was prepared in the same way, without the reverse transcriptase. 
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4.6 Semi-quantitative RT-PCR 
 
To ensure equal amounts of cDNA as template loading contros were performed 
amplifying the housekeeping gene Glyceral-Aldehyde-3-Phosphate (Gapdh) a central 
component of glycolysis. For better visualisation of alterations in the expression ratio 
between the WT and GOF a 1:5 dilution was used in addition to undiluted cDNA. The 
PCR conditions and primers are shown below: 
 
PCR-Mix 
 
Takara Taq (RR001A) (5 units/µl) 0,2µl  
10x PCR Buffer (incl. 1,5 mM MgCl2) 2µl 
dNTP Mixture (2,5 mM each) 2µl 
Template  1µl for Gapdh, 3µl all other genes 
Primer 1 (10 pM) 1µl 
Primer 2 (10 pM) 1µl 
Milli Q H2O Up to 20µl 
  
 
PCR-Program 
 
95 °C 5’ 
94 °C 45’’ 
60 °C           29 Cycles (Gapdh), 34 cycles (all other Genes) 45’’ 
72 °C 40’’ 
72 °C 5’ 
4 °C  
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Primers 
 
All Primers for semi-quantitative PCR were designed using Primer3 (Rozen and 
Skaletsky 2000) and span at least 1 Intron/Exon boundary. Product lengths varied 
between 400-500bp (Gapdh: 700bp). In addition PCRs were carried out for all 
primers at the same conditions however with the –RT control to test for genomic DNA 
contaminations.  
 
Stock # Gene Sequence 
HAR84 Gapdh fw CAAATGGGGTGAGGCCGGTGCTGAGTAT 
HAR85 Gapdh rev CGGCATCGAAGGTGGAAGAGTGGGAGTT 
HAR1888 Pik3r1 fw TGACGAGAAGACGTGGAATG 
HAR1889 Pik3r1 rev CATCGCCTCTGTTGTGCAT 
HAR1919 Foxo3 fw CTGTCCTATGCCGACCTGAT 
HAR1920 Foxo3 rev CCTCGGCTCTTGGTGTACTT 
HAR2033 Dusp19 fw GTTCCTTGACGAAGCTCTGC 
HAR2034 Dusp19 rev AGTCGTCTCCATCCTGTGCT 
HAR2122 Tcf4 fw  TCATATCCCACAGTCCAGCA 
HAR2123 Tcf4 rev TTCCAAACGGTCTTCGATTC 
HAR2124 Wif1 fw CTCCCTGGATAAAGGCATCA 
HAR2125 Wif1 rev TGGTTGAGCAGTTTGCTTTG 
HAR2130 Eya3 fw TTTCGCTTCAAGCACAAATG 
HAR2131 Eya3 rev CCGTTCCAATTCACTGTCCT 
HAR2132 IRX5 fw TACAGCACCAGCGTCATTTC 
HAR2133 IRX5 rev ACCTGGGTGAGGGTCATCTT 
HAR2136 Prkcb1 fw GGATCGCTGCTGTATGGACT 
HAR2137 Prkcb1 rev CCCATGAAGTCATTCCTGCT 
HAR2138 Gnai1 fw GGCAGTGGTCTACAGCAACA 
HAR2139 Gnai1 rev GATCCACTTCTTCCGCTCTG 
HAR2140 Runx1 fw CTTCCTCTGCTCCGTGCTAC 
HAR2141 Runx1 rev GCTGAGGGTTAAAGGCAGTG 
 
After the PCR 3µl of loading buffer were added, the tubes were vortexed and 
centrifuged. Then 15µl of each sample were loaded on the gel. 
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4.7 Luciferase-Reporter Assays 
 
For the luciferase reporter assays 293T cells were used. 24 hours before the 
transfection 8x104 cells/well were seeded into 24 well plates.  
For each condition tested 4 wells were transfected with the same trasfection-mix, 
therefore the mix was prepared for 4 wells at a time. First water was added in a 
calculated amount resulting in an end volume of 50µl/well. Then per well 0,5µg of the 
luciferase reporter construct and 0,05µg of the Renilla expression vector for 
normalization were added. The factors to be tested were added in concentrations as 
indicated in the results section, typically ranging from 0,25µg to 1µg per well. Finally 
2M 7µl of CaCl2 per well were added. All constructs used are shown in table below. 
The mixture for the 4 wells (200µl) was then vortexed and added drop wise to a 5ml 
polystyrene tube containing 200µl of 2x HBS pH 7,05, while bubbling with a 2ml 
plastic pipette. From this mix 100 µl were added to each well and cells were 
incubated for 24h at 37 °C. 
 
Luciferase measurements were made on the following day. The media was removed 
and 100 µl luciferase buffer (Promega Dual-Glo Luciferase Assay) mixed 1:1 with 
DMEM 1% FCS was added per well. The plate was incubated for 15‘ on a shaker and 
afterwards 50µl of the solution were pipetted on a 96-well plate. After measurement 
in the luminometer (Synergy Szabo-Scandic), 50 µl of the Dual-Glo & Stop (1:100) 
were added and incubated again for 10’ before the measurement. In addition a blank 
with Luciferase buffer (Promega Dual-Glo Luciferase Assay) mixed 1:1 with DMEM 
was treated the same way as the samples. All steps steps after addition of the 
Luciferase Buffer were carried out in the dark.  
 
The blank was subtracted from the measured values and the signal of the Renilla 
was used to normalize the results. The average of the 4 wells was calculated if 
present the strongest outlier was not included in the calculation. For each condition at 
least 3 independent measurements were conducted and the average and standard 
error was calculated. For the p-value calculation a two tailed t-test for unpaired 
samples with same variance was used.  
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Stock # Construct 
722 Renilla expression vector 
755 β-catenin expression vector 
763 Lef1 expression vector 
876 2,9kb Sox9-Promoter pGL4.10 
923 TCF1 expression vector 
924 Tcf1/β-catenin-fusion exp. vector 
1056 TCF4A longisof in pcDNA3.1 
1057 IRX5 in pcDNA 3.1 
1058 FRA2 in pcDNA3.1 
1059 2,5kb CyclinD1-Prmoter pGL 4.10 
1060 2,4kb Tcf7l2-Promoter pGL 4.10 
1062 2,3kb TCF4A-Promoter pGL4.10 
1064 1,9kb IRX5-Promoter pGL4.10 
1065 1,9kb Fra2-Promoter pGL4.10 
 
4.8 Cloning work 
 
Ligation 
 
Ligation was carried out with Takara Ligation Kit according to the protocol supplied by 
the manufacturer. 
 
Transformation in E.coli 
 
80 µl competent DH5α cells were added to the plasmid, incubated for 15‘ on ice , 
exposed to heatshock at 42 °C for 1’ and incubated 5’ on ice before plating. As only 
AMP-resistance was used for transfections it was not necessary to recover cells in 
LB before plating. 
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Miniprep/Maxiprep 
 
Qiagen Miniprep/Maxiprep and Promega Maxiprep kits were used for these purposes 
and all steps were conducted according to the standard protocol provided by the 
manufacturer. 
 
Agarose gel and Gel elution 
 
The PCR-products and restriction digests were separated on 1% Agarose gels and 
Qiaquick Gel Purification kit was used for purification according to the protocol 
provided by the manufacturer. 
 
Isolation of genomic DNA 
 
A mouse tail was incubated with 0,5ml of 50mM Tris (ph8), 100 mM EDTA, 0,5% 
SDS and 25 µl of a 10 mg/ml solution of proteinaseK at 55 °C ov er night. On the next 
day an extraction with 0,5 ml phenol:chlorophorm:isoamylalkohol (PCI/Sigma) (pH 8) 
was repeated for two times and to the remaining aqueous phase 50µl of 3M sodium 
acetate (pH 6) and 0,5 ml 100% Ethanol were added to precipitate the DNA. The 
DNA was then washed with 70% Ethanol, dried and resolved in 50µl TE. Successful 
DNA isolation was checked on a 0,8% agarose gel.  
 
BAC-Isolation 
 
For the Isolation of BACs a single colony was picked, inoculated to 200 ml of 
LB+Chloramphenicol (25 µg/ml) and grown overnight. For the preparation a Qiagen 
Midi Kit was used according to the standard protocol with the only modification that 
the elution buffer was heated to 65 °C for more eff icient elution. 
 
Verification of PCR-products 
 
Taq amplified PCR-products were ligated into pGEM-T (Promega) using the A/T 
overlap generated by the polymerase and transformed into E.coli. The bacteria were 
then grown over night or for at least 8 hours before the plasmids were isolated by 
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miniprep. The inserts of the isolated plasmid DNA were then verified using an 
appropriate restriction strategy and if necessary sequenced. 
 
PCR-Conditions 
 
All PCRs for cloning purposes were carried out with the following PCR-Mix and 
program according to (Ralser, Querfurth et al. 2006) who propose the following 
enhancer mix and PCR-conditions.  
 
 
Single reaction Mix (25µl) 
dntps 2,5mM Takara 2,5 
10x Buffer incl MgCl2 Takara 2,5 
Primer1 10pM 0,5 
Primer2 10pM 0,5 
TAQ (Takara) 0,2 
Template 1 
bsa 1mg/ml 0,275 
Dmso (Sigma-Aldrich) 0,335 
Betaine (3M) 4,5 
DTT 1M (Invitrogen) 0,335 
Sum 12,145 
dH20 12,855 
Total mix 25 
 
PCR-Program: 
 
Initial denaturation 95 °C 5’ 
Denaturation 98 °C 10’’ 
Annealing 62 °C -0,5°/cycle 45’’ 
Elongation 72 °C 10’’ per 0,1 kb 
Denaturation 98 °C 10’’ 
Annealing 52 °C 45’’ 
Elongation 72 °C  10’’ per 0,1 kb 
Final Elongation 72 °C  5’ 
Storage 4 °C  
Touchdown phase 
20 cycles 
Amplification phase 
15-20 cycles 
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Cloning of promoter-fragments for Luciferase-Promoter Assays 
 
All promoters in the thesis were cloned in a way that they include at least the first 30 
bp of the transcript. This is to ensure that the transcriptional start site is within the 
construct and no minimal promoter provided by the luciferase vector was needed.  
An overview of the cloning strategies including construct lengths and the Luciferase 
vector pgl4.10 is depicted in Fig. 29 A. 
For CyclinD1 and Tcf7l2 the strategy was to ligate two overlapping PCR-products 
that contained a common endogenous restriction site. For the other genes primers 
were used that spanned the entire length as shown in Fig. 29 A. For ligation into 
pgl4.10 (Fig. 29 B) the necessary restriction sites were added to the primers or 
endogenous sites within the PCR-Products were used. 
 
Stock# Gene Purpose Sequence Comment 
HAR2166 Tcf4a Rev2+XhoI TTCTCGAGGGCACTGCGGCTTATAAAGA  
HAR2167 Tcf4a Fw1 TCAGGCTGGCCTCTATGATT Endogenous SacI site 
HARXX! Tcf4a Sequencing TGGGGGATAAAACACTGGAG  
HAR2212 Irx5 Fw1 GGACCAGAGCCGAGACACT Endogenous SacI site 
HAR2213 Irx5 Rev2+BglII TTAGATCTCTCCCTCGCTCTTTGCAC  
HAR2231 Irx5 Sequencing GAACTCTGCCTGGGACTCTG  
HAR2278 Fra2 Fw1 CCTGCAGAGCTGCACATTCT Endogenous SacI site 
HAR2279 Fra2 Rev2+Nhe1 AAGCTAGCCGCTCGCTCTCTTTCTCTCT  
HAR2283 Fra2 Sequencing GCCTGCCCATTTTTCACTC  
HAR1600 Cdkn1 Fw1+Kpn1 TTGGTACCTTGGCTCCAGTCAGGTGG  
HAR1599 Cdkn1 Rev1 AGTTATTAGTCGCCCTTCC  
HAR1596 Cdkn1 Fw2 TGGAGAAACACCACCACC  
HAR1597 Cdkn1 Rev2+BglII AAAGATCTGAGTCTGTAGCTCTCTGC  
HAR1602 Tcf7l2 Fw1+NheI TTGCTAGCTCTCCCTCTTAGATACTGC  
HAR1603 Tcf7l2 Rev1 AACTGACGTTGGAAGTAGG  
HAR1604 Tcf7l2 Fw2 CTCCAGCTCTACTCATCC  
HAR1605 Tcf7l2 Rev2+HindIII TTAAGCTTTCACCCACCAGCAGCAGC  
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Fig. 29: Overview of the cloning strategies. 
On top 1 part PCR strategy on bottom 2 
part PCR (A). Luciferase Vector Promega 
pgl 4.10 (B)  
 
In case were I did not succeed to amplify the product by PCR using genomic mouse 
DNA as a template I used BAC-clones of the corresponding genomic loci as 
templates. BAC-IDs are shown in the table below 
 
 
Construct  Template 
Tcf4 Genomic WT-DNA 
Irx5 RP24-69M8 
CyclinD1 RP23-107I11 
Tcf7l2 RP23-342F10 
Fra2 RPCI-24-255I2 
 
Cloning of cDNA-constructs 
 
For the generation of functional cDNA clones containing the entire open reading 
frame (Luo, McMullen et al.) primers were targeted to the 5’ and 3’ regions 
neighbouring the coding region. This was particularly important as the 5’ UTR 
contains the Kozak sequence (gccrccAUGG) which signals the start of translation to 
the ribosome (Kozak 1987) . Amplification of the full length cDNAs including the 3’ 
UTR was not necessary as all the vectors used contained additional sequences 
providing the polyadenylation signals. Restrictions sites were added to the primers to 
facilitate integration of the  resulting constructs into the following 2 vectors: 
B 
A 
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• An in vivo expression construct, for limb mesenchyme specific expression 
under the Prx1-promoter (Logan, Martin et al. 2002) (Fig. 30 A) 
• pcDNA3.1(+) a vector for overexpression in tissue culture (Fig 30 B) 
 
 
 
Fig. 30: Prx1-Promoter construct as 
received by M. Logan (A).  
 
Invitrogen pcDNA3.1 expression vector 
(B) 
 
Correct insertion into the Prx1 vector backbone was verified by sequencing from the 
T7 promoter in the backbone. The following primers were used for amplification of the 
constructs, with the PCR-program described above.  
 
Primer Gene+RE Sequence 
Construct 
Lenght 
HAR2204 Fra2 fw+EcoRI,BamHI TTGAATTCGGATCCGGGAAGAAAACCACCCTGTT 
HAR2205 Fra2 rev+EcoRI AAGAATTCTCGCTTGCAAGATGAATGAG 
1,2kb 
HAR2206 Irx5 fw+EcoRI, Bgl2 AAGAATTCAGATCTAGAAGCCAGGTGCCCTCTC 
HAR2207 Irx5 rev+EcoRI AAGAATTCGCCAAGGCCATGGTTTTAAT 
1,6kb 
HAR2209 Tcf4a rev+EcoRI AAGAATTCAAACGGGGTTAAGGAGCAGT 
HAR2216 Tcf4a fw+EcoRI,BamHI TTGAATTCGGATCCCTCTTTTGGGGGAACACTCA 
2,3kb 
 
After amplification the constructs were ligated into Promega pGEM-T-easy with using 
the A/T overlaps resulting from the Taq PCR amplification. A number of clones were 
sequenced to find error free coding regions. For Irx5 and Tcf4 the following 
sequencing primers were necessary to span the centre parts of the constructs.  
 
A 
B 
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HAR2224 Irx5 AGAAGATCATGCTGGCCATT 
HAR2225 Tcf4a TGCCATGGAGGTACAGACAA 
 
For Tcf4a no clone without errors could be identified, therefore the error free 5’, and 
3’ part originating from two different clones were combined using the internal XbaI 
site.  
 
4.9 Preparation of Tcf4a plasmid for pro-nucleus injection 
 
10µg of the plasmid were digested with NotI/ClaI (Fig 30 A) and separated on a gel. 
The 7kb band of the injection-construct was cut out and purified with the Qiagen 
Purification Kit according to the standard protocol provided by the manufacturer, with 
the slight modification that the elution from the column was carried out using injection 
buffer supplied by the mouse IMP/IMBA mouse service. Injections were carried out 
by the IMP/IMBA service. 
 
4.10 Genotyping of transient transgenic embryos 
 
For the genotyping Primers Har2122 and 2123 were used. Primers and Pcr-
conditions as described in the Section 4.6 Semi-quantitative RT-PCR. 1µl of yolk sac 
preped genomic DNA was used as template. WT-DNA was used as negative control, 
the injected plasmid as positive control. 
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